(19)
(11)EP 3 360 927 B1

(12)EUROPEAN PATENT SPECIFICATION

(45)Mention of the grant of the patent:
09.09.2020 Bulletin 2020/37

(21)Application number: 18159665.1

(22)Date of filing:  25.06.2010
(51)International Patent Classification (IPC): 
C08L 67/04(2006.01)
C08J 5/18(2006.01)
C08G 63/08(2006.01)
C08L 101/16(2006.01)

(54)

PHA COMPOSITIONS COMPRISING PBS AND PBSA AND METHOD FOR PRODUCING THE COMPOSITIONS

PHA-ZUSAMMENSETZUNGEN MIT PBS UND PBSA SOWIE VERFAHREN ZU DEREN HERSTELLUNG

COMPOSITIONS DE PHA COMPRENANT DU PBS ET DU PBSA ET LEUR PROCÉDÉ DE PRODUCTION


(84)Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR

(30)Priority: 26.06.2009 US 269582 P

(43)Date of publication of application:
15.08.2018 Bulletin 2018/33

(62)Application number of the earlier application in accordance with Art. 76 EPC:
10792744.4 / 2445965

(73)Proprietor: CJ CheilJedang Corporation
Seoul 04560 (KR)

(72)Inventors:
  • KRISHNASWAMY, Rajendra, K.
    Pittsburgh, PA Pennsylvania 15241 (US)
  • SUN, Xiudong
    Arlington, MA Massachusetts 02474 (US)

(74)Representative: Snodin, Michael D. 
Park Grove IP BioCity Nottingham Pennyfoot Street
Nottingham NG1 1GF
Nottingham NG1 1GF (GB)


(56)References cited: : 
EP-A1- 1 944 333
WO-A2-99/23161
US-A1- 2004 225 269
WO-A1-2009/137058
JP-A- 2007 161 957
US-B1- 6 579 934
  
      
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).


    Description

    RELATED APPLICATION



    [0001] This application is a divisional of European patent application no. 10792744, which granted as EP 2 445 965 B1 on 8 August 2018 and which stemmed from WO 2010/151798 A2 (published on 25 June 2010 and entitled "PHA compositions comprising PBS and PBSA and methods for their production").

    BACKGROUND



    [0002] Biodegradable plastics are of increasing industrial interest as replacements or supplements for non-biodegradable plastics in a wide range of applications and in particular for packaging applications. One class of biodegradable polymers is the polyhydroxyalkanoates (PHAs), which are linear, aliphatic polyesters that can be produced by numerous microorganisms for use as intracellular storage material. Articles made from the polymers are generally recognized by soil microbes as a food source. There has therefore been a great deal of interest in the commercial development of these polymers, particularly for disposable consumer items. The polymers exhibit good biodegradability and useful physical properties.

    [0003] In some applications, the rapid biodegradability of PHAs is a problem, and therefore a need exists for compositions that assist in controlling the rate of biodegradation of PHAs.

    SUMMARY OF THE INVENTION



    [0004] In accordance with embodiments of the invention, compositions of branched polymer compositions comprising polyhydroxyalkanoates (PHAs) and polybutylene succinate adipate (PBSA) are provided. The PHAs are reactive blended with the PBSA. In particular, when the polymers are melt-blended in the presence of a branching agent, for example, organic peroxide, (e.g., reactive blending or reactive melt blending) the resultant compositions display many unexpected synergies in melt rheology, melt stability, processing and properties, such as film processing and film properties. In addition, the biodegradation kinetics of PHB copolymers can be slowed down by combining some PBSA into the composition. In certain aspects, the process of reactive blending further includes the use of a reactive cross-linking agent resulting in improved properties. In one embodiment, the PHA and PBSA are blended, i.e., to a homogenous blend. In certain aspects, the polymers of the compositions are mixed together to form a blend. WO 2009/137058 A1, entitled "Biodegradable polyester blends", was published on 12 November 2009. US 6,579,934 B1, entitled "Reactive extrusion process for making modifiied biodegradable compositions", was published on 17 June 2003. WO 99/23161 A2, entitled "Polymer blends containing polyhydroxyalkanoates and compositions with good retention of elongation", was published on 14 May 1999. US 2004/225269 A1, entitled "Molded or extruded articles comprising polyhydroxyalkanoate copolymer and an environmentally degradable thermoplastic polymer", was published on 11 November 2004. EP 1 944 333 A1, entitled "Biodegradable resin foam sheet, biodegradable resin foam article and biodegradable resin molded container" was published on 16 July 2008. JP 2007 161957 A, entitled "Resin composition and molding comprising the same" was published on 28 June 2007.

    [0005] In related embodiments, reacting with a branching agent is performed in the presence of a co-agent (also referred to herein, as a "cross-linking agent), thereby forming a branched polymer blend. The conditions of the reaction are suitable for reacting the branching agent alone or with a cross-linking agent and a polymer blend. A "branched" polymer is a polymer with a branching of the polymer chain or cross-linking of two or more polymer chains.

    [0006] The cross-linking agent when reacted, for example, at its epoxide group(s) or double bond(s), becomes bonded to another molecule, e.g., a polymer or branched polymer. As a consequence the multiple molecules become cross-linked through the reactive group on the cross-linking agent. An "epoxy functional compound" is a cross-linking agent comprising two or more epoxy functional groups.

    [0007] In accordance with other related aspects of the invention, the functional group of the cross-linking agent is an epoxy-functional compound, for example, an epoxy-functional styrene-acrylic polymer, an epoxy-functional acrylic copolymer, an epoxy-functional polyolefin copolymer, oligomers comprising glycidyl groups with epoxy functional side chains, an epoxy-functional poly(ethylene-glycidyl methacrylate-co-methacrylate), or an epoxidized oil, poly(ethylene-co-methacrylate-coglycidyl methacrylate), ethylene-n-butyl acrylate-glycidyl methacrylate or combinations thereof.

    [0008] In another related embodiment, the cross-linking agent contains at least two reactive double bonds. These cross-linking agents include but are not limited to the following: diallyl phthalate, pentaerythritol tetraacrylate, trimethylolpropane triacrylate, pentaerythritol triacrylate, dipentaerythritol pentaacrylate, diethylene glycol dimethacrylate, bis(2-methacryloxyethyl) phosphate, or combinations thereof.

    [0009] In accordance with other related embodiments, a method of preparing a branched polymer composition is described, comprising reacting a PHA and PBSA with a branching agent, and forming a branched polymer composition comprising a branched PHA and PBSA blend. In certain embodiments, the method wherein the composition further comprises PBSA.

    [0010] Additives may also be included in the compositions and methods of the inventions. In particular embodiments, a nucleating agent is added.

    [0011] Also described is a method of preparing a film comprising a branched polymer composition, comprising reacting a PHA with a branching agent, thereby forming a branched PHA polymer composition, reacting a PBSA with a branching agent, thereby forming a branched PBSA polymer composition, exposing the branched PHA composition to conditions that cause melting of the PHA, thereby forming a molten branched PHA composition, exposing the branched PBSA composition to conditions that cause melting of the PBSA, thereby forming a molten branched PBSA composition, co-extruding the molten PHA compositions and the molten PBSA compositions to form a multi-layered film; thereby making a film comprising branched PHA and branched PBSA.

    [0012] In yet another method an article is prepared comprising a branched PHA and branched PBSA composition comprising the steps of: melt-blending PHA and PBSA and a branching agent under conditions that cause melting and branching of the PHA polymer and the PBSA, thereby forming a molten branched polymer composition; and forming an article from the branched molten polymer composition; thereby making an article comprising branched polymer composition of branched PHA and branched PBSA.

    [0013] In certain embodiment, a film is prepared by the methods described herein, the resultant film has greater tear resistance according to ASTM D1922-06, greater puncture resistance according to D1709-04, or greater tensile strength according to D882-02 than a corresponding PHA film made without PBSA. In some aspects, the film possesses properties that are 25% greater, 50% greater or 75-100% greater. The film is a blend of branched PHA and branched PBSA.

    [0014] In accordance with another related aspects, compositions are described that comprise branched PHA and branched PBSA. In particular embodiments, the PHA is a PHA blend of about 58-62% homo-polymer of 3-hydroxybutanoic acid, and about 38-42% copolymer of 3-hydroxybutanoic acid and 4-hydroxybutanoic acid, where the 4-hydroxybutanoic acid is about 8-14% weight percent or a PHBV with the hydroxyvalerate is about 7% weight percent or a blend of a copolymer of about 34-38% homo-polymer of 3-hydroxybutanoic acid, and about 22-26% co-polymer of 3-hydroxybutanoic acid and 4-hydroxybutanoic acid, where the 4-hydroxybutanoic acid is approximately 8-14 weight percent, and a copolymer of about 38-42% co-polymer of 3-hydroxybutanoic acid and 4-hydroxybutanoic acid with the 4-hydroxybutanoic acid composition being nominally 25-33 weight percent.

    BRIEF DESCRIPTION OF THE DRAWINGS



    [0015] 

    FIG. 1 is a plot showing apparent Viscosity vs. time.

    FIG. 2 is a plot showing G' of vs. Wt % PBS.

    FIG. 3 is a plot showing capillary stability vs. Wt % PBS.

    FIG. 4 is a plot showing G' of vs. Wt % PBSA.

    FIG. 5 is a plot showing capillary stability vs. Wt % PBSA.

    FIG. 6 is a plot of formulations vs. controls.

    FIG. 7 is a plot showing G' of vs. Wt % PBS in Blend.

    FIG. 8 is a plot showing capillary stability vs. Wt % PBS in Blend.

    FIG. 9 is a photo demonstrating different percentage of the blend in injection molded test bars.

    FIG. 10 is a plot showing weight loss of the 12 different formulations of Table 10.

    FIG. 11 is a plot showing weight loss of the 8 different formulations of Table 13.


    DETAILED DESCRIPTION



    [0016] This invention relates to compositions comprising polyhydroxyalkanoates (PHAs) and poly (butylene succinate adipate) (PBSA) reacted with branching agents, methods of making the compositions, and articles made from the compositions. The compositions are useful in applications such as articles, including film, injection molded articles, sheets, foam and thermoformed articles.

    [0017] Combining (e.g, mixing or blending) the polymer blends in the presence of peroxide provides the following benefits compared to combining the polymer blends without any reactive chemistry: (1) higher melt strength, (2) improved melt stability and/or better melt capillary stability, resulting in a broader processing window for the overall composition, (3) synergistic film properties, e.g., film tear properties of the compositions are better than PHA or PBSA film by itself, (4) higher toughness for injection molded bars, and (5) lower flash during injection molding process.

    [0018] The use of cross-linking agents (co-agents) further improve the desired properties of the polymer composition over the starting compositions without the cross-linking agents and branching agents. In one aspect, the cross-linking agents comprise two or more reactive groups such as double bonds or epoxides. These cross-linking agents react with and become covalently bonded (connected) to the polymer. The connection of multiple chains through these cross-linking agents form a branched polymer. The branched polymer has increased melt strength over the melt strength of the starting polymer.

    [0019] Increased melt strength is useful in that it allows the polymers to be formed under a broader temperature range when the polymer is processed. This property for broader processing temperatures for polymer applications, such as in the production of blown film (i.e., in preventing or reducing bubble collapse), or cast film extrusion, thermoformed articles (i.e., preventing or reducing sheet sag during thermoforming), profile extruded articles (i.e., preventing or reducing sag), non-woven fibers and monofilament.

    [0020] The polymers' stability is effected at processing temperatures and can accordingly experience a drop in melt strength. This can cause difficulties in processing these polymers. These shortcomings are addressed by the compositions and methods of the invention. Additionally, the improvement shown in films made from the methods and compositions described herein are greater tensile strength, tear resistance and greater puncture resistance.

    [0021] The methods and branched compositions of the invention improve the melt strength of polymer compositions, a desirable property for many polymer product applications. Melt strength is a rheological property that can be measured a number of ways. One measure is G.' G' is the polymer storage modulus measured at melt processing temperatures.

    [0022] Physical properties and rheological properties of polymeric materials depend on the molecular weight and distribution of the polymer. "Molecular weight" is calculated in a number of different ways. Unless other wise indicated, "molecular weight" refers to weight average molecular weight.

    [0023] "Number average molecular weight" (Mn) represents the arithmetic mean of the distribution, and is the sum of the products of the molecular weights of each fraction, multiplied by its mole fraction (∑NiMi/∑Ni).

    [0024] "Weight average molecular weight" (Mw) is the sum of the products of the molecular weight of each fraction, multiplied by its weight fraction

    Mw is generally greater than or equal to Mn.

    [0025] One way of increasing the melt strength is by branching the polymers (PHA, PBS and PBSA and combinations thereof), and various methods for accomplishing this are described herein. Branching of PHA is a result of reacting with branching agents, for example, peroxides. Also, cross-linking agents, for example, reactive compounds (compounds with epoxy groups and compounds with reactive double bonds) that enhance or increase the branching of the polymer, can also be used.

    [0026] Addition of other reactive polymeric compounds, such as reactive acrylics, can also be employed to the rate of branching architecture of the PHA. The use and selection of additives to these compositions result in improved properties. All of these methods are described herein.

    POLYBUTYLENE SUCCINATE AND POLY BUTYLENE SUCCINATE ADIPATE



    [0027] Poly butylene succinate (PBS) and poly butylene succinate adipate (PBSA) are synthetic, petroleum-based aliphatic polyesters, made by condensation polymerization followed by chain extension using multi-functional isocyanates. PBS is a combination of 1,4 butane diol and succinic acid, while PBSA is a combination of 1,4 butane diol, succinic acid, and adipic acid. Although usually synthesized from petroleum, it is also possible for the monomers that make up PBS and PBSA to be produced from biobased feedstock.

    [0028] PBS and PBSA are commercially available for example from, Showa HighPolymer, Japan; SkyGreen BDP, Korea; and SK Polymer, Ire Chemicals Co., Korea; and Sqehan Co, Korea; among others.

    [0029] The two polymers are reportedly biodegradable at ambient temperatures (i.e., are "cold compostable") in soil and marine conditions. PBS degrades more slowly compared to PBSA. PBS is hydro-biodegradable and begins to biodegrade via a hydrolysis mechanism. Hydrolysis occurs at the ester linkages and this results in a lowering of the polymer's molecular weight, allowing for further degradation by micro-organisms. Further, PBS and PBSA are known to biodegrade more slowly than PHAs, which are also cold-compostable.

    [0030] Of the two, PBS has higher crystallinity, and is better suited for molding, while PBSA has lower crystallinity, is better suited to film applications. Both polymers have a low (sub-zero) glass transition temperature (Tg), and their processing temperatures overlap with PHAs. As disclosed herein, PHA polymers can be combined with PBS and/or PBSA using conventional melt-blending techniques. In this invention, the above-mentioned blends are melt-blended in the presence of a reactive entity such as organic peroxide branching agents; branching co-agents may also be used. The reactive blending approach produces compositions that have considerably better melt and solid-state properties compared to the non-reactive blends. In particular, the reactive (inventive) blends have higher melt strength, broader processing window, and better mechanical properties. As shown herein, the crystallization of PHA is influenced significantly by the presence of even small amounts of PBS and/or PBSA. Reactive blends were found to process very well, with improved antiblocking behavior, higher line speeds and better roll-release behavior. Addition of PBS and/or PBSA to PHAs improved the tear, puncture, and tensile strength performance of PHA films. In general, PBSA performed better when blended with PHA than did PBS. Reactive blending resulted in considerably better performance characteristics of the finished film relative to equivalent dry blends. Addition of as little as 25% PBSA doubled the tear and puncture resistance of PHA films. The addition of PBS and PBSA also reduced flash in injection molding applications.

    POLYHYDROXYALKANOATES (PHAS)



    [0031] Polyhydroxyalkanoates are biological polyesters synthesized by a broad range of natural and genetically engineered bacteria as well as genetically engineered plant crops (Braunegg et al., (1998), J. Biotechnology 65:127-161; Madison and Huisman, 1999, Microbiology and Molecular Biology Reviews, 63:21-53; Poirier, 2002, Progress in Lipid Research 41:131-155). These polymers are biodegradable thermoplastic materials, produced from renewable resources, with the potential for use in a broad range of industrial applications (Williams & Peoples, CHEMTECH 26:38-44 (1996)). Useful microbial strains for producing PHAs, include Alcaligenes eutrophus (renamed as Ralstonia eutropha), Alcaligenes latus, Azotobacter, Aeromonas, Comamonas, Pseudomonads, and genetically engineered organisms including genetically engineered microbes such as Pseudomonas, Ralstonia and Escherichia coli.

    [0032] In general, a PHA is formed by enzymatic polymerization of one or more monomer units inside a living cell. Over 100 different types of monomers have been incorporated into the PHA polymers (Steinbüchel and Valentin, 1995, FEMS Microbiol. Lett. 128:219-228. Examples of monomer units incorporated in PHAs include 2-hydroxybutyrate, lactic acid, glycolic acid, 3-hydroxybutyrate (hereinafter referred to as 3HB), 3-hydroxypropionate (hereinafter referred to as 3HP), 3-hydroxyvalerate (hereinafter referred to as 3HV), 3-hydroxyhexanoate (hereinafter referred to as 3HH), 3-hydroxyheptanoate (hereinafter referred to as 3HHep), 3-hydroxyoctanoate (hereinafter referred to as 3HO), 3-hydroxynonanoate (hereinafter referred to as 3HN), 3-hydroxydecanoate (hereinafter referred to as 3HD), 3-hydroxydodecanoate (hereinafter referred to as 3HDd), 4-hydroxybutyrate (hereinafter referred to as 4HB), 4-hydroxyvalerate (hereinafter referred to as 4HV), 5-hydroxyvalerate (hereinafter referred to as 5HV), and 6-hydroxyhexanoate (hereinafter referred to as 6HH). 3-hydroxyacid monomers incorporated into PHAs are the (D) or (R) 3-hydroxyacid isomer with the exception of 3HP which does not have a chiral center.

    [0033] In some embodiments, the PHA in the methods described herein is a homopolymer (where all monomer units are the same). Examples of PHA homopolymers include poly 3-hydroxyalkanoates (e.g., poly 3-hydroxypropionate (hereinafter referred to as P3HP), poly 3-hydroxybutyrate (hereinafter referred to as PHB) and poly 3-hydroxyvalerate), poly 4-hydroxyalkanoates (e.g., poly 4-hydroxybutyrate (hereinafter referred to as P4HB), or poly 4-hydroxyvalerate (hereinafter referred to as P4HV)) and poly 5-hydroxyalkanoates (e.g., poly 5-hydroxyvalerate (hereinafter referred to as P5HV)).

    [0034] In certain embodiments, the starting PHA can be a copolymer (containing two or more different monomer units) in which the different monomers are randomly distributed in the polymer chain. Examples of PHA copolymers include poly 3-hydroxybutyrate-co-3-hydroxypropionate (hereinafter referred to as PHB3HP), poly 3-hydroxybutyrate-co-4-hydroxybutyrate (hereinafter referred to as PHB4HB), poly 3-hydroxybutyrate-co-4-hydroxyvalerate (hereinafter referred to as PHB4HV), poly 3-hydroxybutyrate-co-3-hydroxyvalerate (hereinafter referred to as PHB3HV), poly 3-hydroxybutyrate-co-3-hydroxyhexanoate (hereinafter referred to as PHB3HH) and poly 3-hydroxybutyrate-co-5-hydroxyvalerate (hereinafter referred to as PHB5HV).

    [0035] By selecting the monomer types and controlling the ratios of the monomer units in a given PHA copolymer a wide range of material properties can be achieved. Although examples of PHA copolymers having two different monomer units have been provided, the PHA can have more than two different monomer units (e.g., three different monomer units, four different monomer units, five different monomer units, six different monomer units) An example of a PHA having 4 different monomer units would be PHB-co-3HH-co-3HO-co-3HD or PHB-co-3-HO-co-3HD-co-3HDd (these types of PHA copolymers are hereinafter referred to as PHB3HX). Typically where the PHB3HX has 3 or more monomer units the 3HB monomer is at least 70% by weight of the total monomers, preferably 85% by weight of the total monomers, most preferably greater than 90% by weight of the total monomers for example 92%, 93%, 94%, 95%, 96% by weight of the copolymer and the HX comprises one or more monomers selected from 3HH, 3HO, 3HD, 3HDd.

    [0036] The homopolymer (where all monomer units are identical) PHB and 3-hydroxybutyrate copolymers (PHB3HP, PHB4HB, PHB3HV, PHB4HV, PHB5HV, PHB3HHP, hereinafter referred to as PHB copolymers) containing 3-hydroxybutyrate and at least one other monomer are of particular interest for commercial production and applications. It is useful to describe these copolymers by reference to their material properties as follows. Type 1 PHB copolymers typically have a glass transition temperature (Tg) in the range of 6 °C to -10 °C, and a melting temperature TM of between 80°C to 180 °C. Type 2 PHB copolymers typically have a Tg of -20 °C to-50°C and Tm of 55 °C to 90°C. In particular embodiments, the Type 2 copolymer has a phase component with a Tg of -15 °C to -45 °C and no Tm.

    [0037] Preferred Type 1 PHB copolymers have two monomer units have a majority of their monomer units being 3-hydroxybutyrate monomer by weight in the copolymer, for example, greater than 78% 3-hydroxybutyrate monomer. Preferred PHB copolymers for this invention are biologically produced from renewable resources and are selected from the following group of PHB copolymers:

    PHB3HV is a Type 1 PHB copolymer where the 3HV content is in the range of 3% to 22% by weight of the polymer and preferably in the range of 4% to 15% by weight of the copolymer for example: 4% 3HV; 5% 3HV; 6% 3HV; 7% 3HV; 8% 3HV; 9% 3HV; 10% 3HV; 11% 3HV; 12% 3HV; 13% 3HV; 14% 3HV; 15% 3HV;

    PHB3HP is a Type 1 PHB copolymer where the 3HP content is in the range of 3% to 15% by weight of the copolymer and preferably in the range of 4% to 15% by weight of the copolymer for example: 4% 3HP; 5% 3HP; 6% 3HP; 7% 3HP; 8% 3HP; 9% 3HP; 10% 3HP; 11% 3HP; 12% 3HP. 13% 3HP; 14% 3HP; 15% 3HP.

    PHB4HB is a Type 1 PHB copolymer where the 4HB content is in the range of 3% to 15% by weight of the copolymer and preferably in the range of 4% to 15% by weight of the copolymer for example: 4% 4HB; 5% 4HB; 6% 4HB; 7% 4HB; 8% 4HB; 9% 4HB; 10% 4HB; 11% 4HB; 12% 4HB; 13% 4HB; 14% 4HB; 15% 4HB.

    PHB4HV is a Type 1 PHB copolymer where the 4HV content is in the range of 3% to 15% by weight of the copolymer and preferably in the range of 4% to 15% by weight of the copolymer for example: 4% 4HV; 5% 4HV; 6% 4HV; 7% 4HV; 8% 4HV; 9% 4HV; 10% 4HV; 11% 4HV; 12% 4HV; 13% 4HV; 14% 4HV; 15% 4HV.

    PHB5HV is a Type 1 PHB copolymer where the 5HV content is in the range of 3% to 15% by weight of the copolymer and preferably in the range of 4% to 15% by weight of the copolymer for example: 4% 5HV; 5% 5HV; 6% 5HV; 7% 5HV; 8% 5HV; 9% 5HV; 10% 5HV; 11% 5HV; 12% 5HV; 13% 5HV; 14% 5HV; 15% 5HV.

    PHB3HH is a Type 1 PHB copolymer where the 3HH content is in the range of 3% to 15% by weight of the copolymer and preferably in the range of 4% to 15% by weight of the copolymer for example: 4% 3HH; 5% 3HH; 6% 3HH; 7% 3HH; 8% 3HH; 9% 3HH; 10% 3HH; 11% 3HH; 12% 3HH; 13% 3HH; 14% 3HH; 15% 3HH;

    PHB3HX is a Type 1 PHB copolymer where the 3HX content is comprised of 2 or more monomers selected from 3HH, 3HO, 3HD and 3HDd and the 3HX content is in the range of 3% to 12% by weight of the copolymer and preferably in the range of 4% to 10% by weight of the copolymer for example: 4% 3HX; 5% 3HX; 6% 3HX; 7% 3HX; 8% 3HX; 9% 3HX; 10% 3HX by weight of the copolymer.

    Type 2 PHB copolymers have a 3HB content of between 80% and 5% by weight of the copolymer, for example 80%, 75%, 70%, 65%, 60%, 55%, 50%, 45%, 40%, 35%, 30%, 25%, 20%, 15%, 10%, 5% by weight of the copolymer.

    PHB4HB is a Type 2 PHB copolymer where the 4HB content is in the range of 20% to 60% by weight of the copolymer and preferably in the range of 25% to 50% by weight of the copolymer for example: 25% 4HB; 30% 4HB; 35% 4HB; 40% 4HB; 45% 4HB; 50% 4HB by weight of the copolymer.

    PHB5HV is a Type 2 PHB copolymer where the 5HV content is in the range of 20% to 60% by weight of the copolymer and preferably in the range of 25% to 50% by weight of the copolymer for example: 25% 5HV; 30% 5HV; 35% 5HV; 40% 5HV; 45% 5HV; 50% 5HV by weight of the copolymer.

    PHB3HH is a Type 2 PHB copolymer where the 3HH is in the range of 35% to 95% by weight of the copolymer and preferably in the range of 40% to 80% by weight of the copolymer for example: 40% 3HH; 45% 3HH; 50% 3HH; 55% 3HH, 60% 3HH; 65% 3HH; 70% 3HH; 75% 3HH; 80% 3HH by weight of the copolymer.

    PHB3HX is a Type 2 PHB copolymer where the 3HX content is comprised of 2 or more monomers selected from 3HH, 3HO, 3HD and 3HDd and the 3HX content is in the range of 30% to 95% by weight of the copolymer and preferably in the range of 35% to 90% by weight of the copolymer for example: 35% 3HX; 40% 3HX; 45% 3HX; 50% 3HX; 55% 3HX 60% 3HX; 65% 3HX; 70% 3HX; 75% 3HX; 80% 3HX; 85% 3HX; 90% 3HX by weight of the copolymer.



    [0038] PHAs for use in the methods, compositions and pellets described in this invention are selected from : PHB or a Type 1 PHB copolymer; a PHA blend of PHB with a Type 1 PHB copolymer where the PHB content by weight of PHA in the PHA blend is in the range of 5% to 95% by weight of the PHA in the PHA blend; a PHA blend of PHB with a Type 2 PHB copolymer where the PHB content by weight of the PHA in the PHA blend is in the range of 5% to 95% by weight of the PHA in the PHA blend; a PHA blend of a Type 1 PHB copolymer with a different Type 1 PHB copolymer and where the content of the first Type 1 PHB copolymer is in the range of 5% to 95 % by weight of the PHA in the PHA blend; a PHA blend of a Type 1 PHB copolymer with a Type 2 PHA copolymer where the content of the Type 1 PHB copolymer is in the range of 30% to 95% by weight of the PHA in the PHA blend; a PHA blend of PHB with a Type 1 PHB copolymer and a Type 2 PHB copolymer where the PHB content is in the range of 10% to 90% by weight of the PHA in the PHA blend, where the Type 1 PHB copolymer content is in the range of 5% to 90% by weight of the PHA in the PHA blend and where the Type 2 PHB copolymer content is in the range of 5% to 90% by weight of the PHA in the PHA blend.

    [0039] The PHA blend of PHB with a Type 1 PHB copolymer is a blend of PHB with PHB3HP where the PHB content in the PHA blend is in the range of 5% to 90 % by weight of the PHA in the PHA blend and the 3HP content in the PHB3HP is in the range of 7% to 15% by weight of the PHB3HP.

    [0040] The PHA blend of PHB with a Type 1 PHB copolymer is a blend of PHB with PHB3HV where the PHB content of the PHA blend is in the range of 5% to 90 % by weight of the PHA in the PHA blend and the 3HV content in the PHB3HV is in the range of 4% to 22% by weight of the PHB3HV.

    [0041] The PHA blend of PHB with a Type 1 PHB copolymer is a blend of PHB with PHB4HB where the PHB content of the PHA blend is in the range of 5% to 90 % by weight of the PHA in the PHA blend and the 4HB content in the PHB4HB is in the range of 4% to 15% by weight of the PHB4HB.

    [0042] The PHA blend of PHB with a Type 1 PHB copolymer is a blend of PHB with PHB4HV where the PHB content of the PHA blend is in the range of 5% to 90 % by weight of the PHA in the PHA blend and the 4HV content in the PHB4HV is in the range of 4% to 15% by weight of the PHB4HV.

    [0043] The PHA blend of PHB with a Type 1 PHB copolymer is a blend of PHB with PHB5HV where the PHB content of the PHA blend is in the range of 5% to 90 % by weight of the PHA in the PHA blend and the 5HV content in the PHB5HV is in the range of 4% to 15% by weight of the PHB5HV.

    [0044] The PHA blend of PHB with a Type 1 PHB copolymer is a blend of PHB with PHB3HH where the PHB content of the PHA blend is in the range of 5% to 90 % by weight of the PHA in the PHA blend and the 3HH content in the PHB3HH is in the range of 4% to 15% by weight of the PHB3HH

    [0045] The PHA blend of PHB with a Type 1 PHB copolymer is a blend of PHB with PHB3HX where the PHB content of the PHA blend is in the range of 5% to 90 % by weight of the PHA in the PHA blend and the 3HX content in the PHB3HX is in the range of 4% to 15% by weight of the PHB3HX.

    [0046] The PHA blend is a blend of a Type 1 PHB copolymer selected from the group PHB3HV, PHB3HP, PHB4HB, PHBV, PHV4HV, PHB5HV, PHB3HH and PHB3HX with a second Type 1 PHB copolymer which is different from the first Type 1 PHB copolymer and is selected from the group PHB3HV, PHB3HP, PHB4HB, PHBV, PHV4HV, PHB5HV, PHB3HH and PHB3HX where the content of the First Type 1 PHB copolymer in the PHA blend is in the range of 10% to 90 % by weight of the total PHA in the blend.

    [0047] The PHA blend of PHB with a Type 2 PHB copolymer is a blend of PHB with PHB4HB where the PHB content in the PHA blend is in the range of 30% to 95 % by weight of the PHA in the PHA blend and the 4HB content in the PHB4HB is in the range of 20% to 60% by weight of the PHB4HB.

    [0048] The PHA blend of PHB with a Type 2 PHB copolymer is a blend of PHB with PHB5HV where the PHB content in the PHA blend is in the range of 30% to 95 % by weight of the PHA in the PHA blend and the 5HV content in the PHB5HV is in the range of 20% to 60% by weight of the PHB5HV.

    [0049] The PHA blend of PHB with a Type 2 PHB copolymer is a blend of PHB with PHB3HH where the PHB content in the PHA blend is in the range of 35% to 95 % by weight of the PHA in the PHA blend and the 3HH content in the PHB3HH is in the range of 35% to 90% by weight of the PHB3HX.

    [0050] The PHA blend of PHB with a Type 2 PHB copolymer is a blend of PHB with PHB3HX where the PHB content in the PHA blend is in the range of 30% to 95 % by weight of the PHA in the PHA blend and the 3HX content in the PHB3HX is in the range of 35% to 90% by weight of the PHB3HX.

    [0051] The PHA blend is a blend of PHB with a Type 1 PHB copolymer and a Type 2 PHB copolymer where the PHB content in the PHA blend is in the range of 10% to 90 % by weight of the PHA in the PHA blend, the Type 1 PHB copolymer content of the PHA blend is in the range of 5% to 90% by weight of the PHA in the PHA blend and the Type 2 PHB copolymer content in the PHA blend is in the range of 5% to 90% by weight of the PHA in the PHA blend.

    [0052] For example a PHA blend can have a PHB content in the PHA blend in the range of 10% to 90% by weight of the PHA in the PHA blend, a PHB3HV content in the PHA blend in the range 5% to 90% by weight of the PHA in the PHA blend, where the 3HV content in the PHB3HV is in the range of 3% to 22% by weight of the PHB3HV, and a PHBHX content in the PHA blend in the range of 5% to 90% by weight of the PHA in the PHA blend where the 3HX content in the PHBHX is in the range of 35% to 90% by weight of the PHBHX.

    [0053] For example a PHA blend can have a PHB content in the PHA blend in the range of 10% to 90% by weight of the PHA in the PHA blend, a PHB3HV content in the PHA blend in the range 5% to 90% by weight of the PHA in the PHA blend, where the 3HV content in the PHB3HV is in the range of 3% to 22% by weight of the PHB3HV, and a PHB4HB content in the PHA blend in the range of 5% to 90% by weight of the PHA in the PHA blend where the 4HB content in the PHB4HB is in the range of 20% to 60% by weight of the PHB4HB.

    [0054] For example a PHA blend can have a PHB content in the PHA blend in the range of 10% to 90% by weight of the PHA in the PHA blend, a PHB3HV content in the PHA blend in the range 5% to 90% by weight of the PHA in the PHA blend, where the 3HV content in the PHB3HV is in the range of 3% to 22% by weight of the PHB3HV, and a PHB5HV content in the PHA blend in the range of 5% to 90% by weight of the PHA in the PHA blend where the 5HV content in the PHB5HV is in the range of 20% to 60% by weight of the PHB5HV.

    [0055] For example a PHA blend can have a PHB content in the PHA blend in the range of 10% to 90% by weight of the PHA in the PHA blend, a PHB4HB content in the PHA blend in the range 5% to 90% by weight of the PHA in the PHA blend, where the 4HB content in the PHB4HB is in the range of 4% to 15% by weight of the PHB4HB, and a PHB4HB content in the PHA blend in the range of 5% to 90% by weight of the PHA in the PHA blend where the 4HB content in the PHB4HB is in the range of 20% to 60% by weight of the PHB4HB.

    [0056] For example a PHA blend can have a PHB content in the PHA blend in the range of 10% to 90% by weight of the PHA in the PHA blend, a PHB4HB content in the PHA blend in the range 5% to 90% by weight of the PHA in the PHA blend, where the 4HB content in the PHB4HB is in the range of 4% to 15% by weight of the PHB4HB, and a PHB5HV content in the PHA blend in the range of 5% to 90% by weight of the PHA in the PHA blend and where the 5HV content in the PHB5HV is in the range of 30% to 90% by weight of the PHB5HV.

    [0057] For example a PHA blend can have a PHB content in the PHA blend in the range of 10% to 90% by weight of the PHA in the PHA blend, a PHB4HB content in the PHA blend in the range 5% to 90% by weight of the PHA in the PHA blend, where the 4HB content in the PHB4HB is in the range of 4% to 15% by weight of the PHB4HB, and a PHB3HX content in the PHA blend in the range of 5% to 90% by weight of the PHA in the PHA blend and where the 3HX content in the PHB3HX is in the range of 35% to 90% by weight of the PHB3HX.

    [0058] For example a PHA blend can have a PHB content in the PHA blend in the range of 10% to 90% by weight of the PHA in the PHA blend, a PHB4HV content in the PHA blend in the range 5% to 90% by weight of the PHA in the PHA blend, where the 4HV content in the PHB4HV is in the range of 3% to 15% by weight of the PHB4HV, and a PHB5HV content in the PHA blend in the range of 5% to 90% by weight of the PHA in the PHA blend where the 5HV content in the PHB5HV is in the range of 30% to 90% by weight of the PHB5HV.

    [0059] For example a PHA blend can have a PHB content in the PHA blend in the range of 10% to 90% by weight of the PHA in the PHA blend, a PHB3HH content in the PHA blend in the range 5% to 90% by weight of the PHA in the PHA blend, where the 3HH content in the PHB3HH is in the range of 3% to 15% by weight of the PHB3HH, and a PHB4HB content in the PHA blend in the range of 5% to 90% by weight of the PHA in the PHA blend where the 4HB content in the PHB4HB is in the range of 20% to 60% by weight of the PHB4HB.

    [0060] For example a PHA blend can have a PHB content in the PHA blend in the range of 10% to 90% by weight of the PHA in the PHA blend, a PHB3HH content in the PHA blend in the range 5% to 90% by weight of the PHA in the PHA blend, where the 3HH content in the PHB3HH is in the range of 3% to 15% by weight of the PHB3HH, and a PHB5HV content in the PHA blend in the range of 5% to 90% by weight of the PHA in the PHA blend where the 5HV content in the PHB5HV is in the range of 20% to 60% by weight of the PHB5HV.

    [0061] For example a PHA blend can have a PHB content in the PHA blend in the range of 10% to 90% by weight of the PHA in the PHA blend, a PHB3HH content in the PHA blend in the range 5% to 90% by weight of the PHA in the PHA blend, where the 3HH content in the PHB3HH is in the range of 3% to 15% by weight of the PHB3HH, and a PHB3HX content in the PHA blend in the range of 5% to 90% by weight of the PHA in the PHA blend where the 3HX content in the PHB3HX is in the range of 35% to 90% by weight of the PHB3HX.

    [0062] For example a PHA blend can have a PHB content in the PHA blend in the range of 10% to 90% by weight of the PHA in the PHA blend, a PHB3HX content in the PHA blend in the range 5% to 90% by weight of the PHA in the PHA blend, where the 3HX content in the PHB3HX is in the range of 3% to 12% by weight of the PHB3HX, and a PHB3HX content in the PHA blend in the range of 5% to 90% by weight of the PHA in the PHA blend where the 3HX content in the PHB3HX is in the range of 35% to 90% by weight of the PHB3HX.

    [0063] For example a PHA blend can have a PHB content in the PHA blend in the range of 10% to 90% by weight of the PHA in the PHA blend, a PHB3HX content in the PHA blend in the range 5% to 90% by weight of the PHA in the PHA blend, where the 3HX content in the PHB3HX is in the range of 3% to 12% by weight of the PHB3HX, and a PHB4HB content in the PHA blend in the range of 5% to 90% by weight of the PHA in the PHA blend where the 4HB content in the PHB4HB is in the range of 20% to 60% by weight of the PHB4HB.

    [0064] For example a PHA blend can have a PHB content in the PHA blend in the range of 10% to 90% by weight of the PHA in the PHA blend, a PHB3HX content in the PHA blend in the range 5% to 90% by weight of the PHA in the PHA blend, where the 3HX content in the PHB3HX is in the range of 3% to 12% by weight of the PHB3HX, and a PHB5HV content in the PHA blend in the range of 5% to 90% by weight of the PHA in the PHA blend where the 5HV content in the PHB5HV is in the range of 20% to 60% by weight of the PHB5HV.

    [0065] The PHA blend is a blend as disclosed in U.S. Pub. App. No. 2004/0220355, by Whitehouse, published November 4, 2004.

    [0066] Microbial systems for producing the PHB copolymer PHBV are disclosed in US patent 4,477,654 to Holmes. U.S. Pat. App. Pub. 2002/0164729, by Skraly and Sholl describes useful systems for producing the PHB copolymer PHB4HB. Useful processes for producing the PHB copolymer PHB3HH have been described (Lee et al., 2000, Biotechnology and Bioengineering 67:240-244; Park et al., 2001, Biomacromolecules 2:248-254). Processes for producing the PHB copolymers PHB3HX have been described by Matsusaki et al. (Biomacromolecules 2000, 1:17-22).

    [0067] In determining the molecular weight techniques such as gel permeation chromatography (GPC) can be used. In the methodology, a polystyrene standard is utilized. The PHA can have a polystyrene equivalent weight average molecular weight (in daltons) of at least 500, at least 10,000, or at least 50,000 and/or less than 2,000,000, less than 1,000,000, less than 1,500,000, and less than 800,000. In certain embodiments, preferably, the PHAs generally have a weight-average molecular weight in the range of 100,000 to 700,000. For example, the molecular weight range for PHB and Type 1 PHB copolymers for use in this application are in the range of 400,000 daltons to 1.5 million daltons as determined by GPC method and the molecular weight range for Type 2 PHB copolymers for use in the application 100,000 to 1.5 million daltons.

    [0068] In certain embodiments, the PHA can have a linear equivalent weight average molecular weight of from about 150,000 Daltons to about 500,000 Daltons and a polydispersity index of from about 2.5 to about 8.0. As used herein, weight average molecular weight and linear equivalent weight average molecular weight are determined by gel permeation chromatography, using, e.g., chloroform as both the eluent and diluent for the PHA samples. Calibration curves for determining molecular weights are generated using linear polystyrenes as molecular weight standards and a 'log MW vs elution volume' calibration method.

    BLENDS OF PHA WITH PBSA



    [0069] In certain embodiments, the polymers for use in the methods and compositions are blended in the presence of additives, branching agents and cross-linking agents to form compositions with improved properties. The percentages of PHA to PBSA are 5% to 95% by weight. In certain compositions of the invention, the percentage of PHA to PBSA of the total polymer compositions ranges from about 95% PHA to about 5% PBSA or about 50% PBSA to about 50% PHA. For example the PHA/PBSA ratio can be 95/5, 90/10, 85/15, 80/20, 75/25, 70/30, 65/35, 60/40, 55/45 or 50/50. BRANCHED POLYHYDROXYALKANOATES, BRANCHED PBS OR BRANCHED PBSA

    [0070] The term "branched polymer" refers to a PHA, PBS or PBSA with branching of the chain and/or cross-linking of two or more chains. Branching on side chains is also contemplated. Branching can be accomplished by various methods. Polyhydroxyalkanoate polymer described above can be branched by branching agents by free-radical-induced cross-linking of the polymer. In certain embodiment, the PHA is branched prior to combination in the method. In other embodiments, the PHA reacted with peroxide in the methods of the invention. The branching increases the melt strength of the polymer. Polyhydroxyalkanoate polymers can be branched in any of the ways described in U.S. U.S. Pat. No. 6,620,869, 7,208,535, 6,201,083, 6,156,852, 6,248,862, 6,201,083 and 6,096,810.

    [0071] The polymers of the invention can be branched according to any of the methods disclosed in WO 2010/008447 titled "Methods For Branching PHA Using Thermolysis" or WO 2010/008445 A2 titled "Branched PHA Compositions, Methods For Their Production, And Use In Applications," both of which were filed in English on June 19, 2009.

    [0072] The invention provides branched PHA copolymer blend compositions with PBSA that do not require the use of a compatibilizer for mixing and blending that other thermoplastic polymer blend compositions require. In these other compositions the compatibilizer is necessary to improve the properties of the blends and increase the compatibility of the polymer composition, especially immiscible polymers.

    BRANCHING AGENTS



    [0073] The branching agents, also referred to a free radical initiator, for use in the compositions and method described herein include organic peroxides. Peroxides are reactive molecules, and can react with polymer molecules or previously branched polymers by removing a hydrogen atom from the polymer backbone, leaving behind a radical. Polymer molecules having such radicals on their backbone are free to combine with each other, creating branched polymer molecules. Branching agents are selected from any suitable initiator known in the art, such as peroxides, azo-dervatives (e.g., azo-nitriles), peresters, and peroxycarbonates. Suitable peroxides for use in the present invention include, but are not limited to, organic peroxides, for example dialkyl organic peroxides such as 2,5-dimethyl-2,5-di(t-butylperoxy) hexane, 2,5-bis(t-butylperoxy)-2,5-dimethylhexane (available from Azko Nobel as TRIGANOX® 101), 2,5-dimethyl-di(t-butylperoxy)hexyne-3, di-t-butyl peroxide, dicumyl peroxide, benzoyl peroxide, di-t-amyl peroxide, t-amylperoxy-2-ethylhexylcarbonate (TAEC), t-butyl cumyl peroxide, n-butyl-4,4-bis(t-butylperoxy)valerate, 1,1-di(t-butylperoxy)-3,3,5-trimethyl-cyclohexane, 1,1-bis(t-butylperoxy)-3,3,5-trimethylcyclohexane (CPK), 1,1-di(t-butylperoxy)cyclohexane, 1,1-di(t-amylperoxy)-cyclohexane, 2,2-di(t-butylperoxy)butane, ethyl-3,3-di(t-butylperoxy)butyrate, 2,2-di(t-amylperoxy)propane, ethyl-3,3-di(t-amylperoxy)butyrate, t-butylperoxy-acetate, t-amylperoxyacetate, t-butylperoxybenzoate, t-amylperoxybenzoate and di-t-butyldiperoxyphthalate. Combinations and mixtures of peroxides can also be used. Examples of free radical initiators include those mentioned herein, as well as those described in, e.g., Polymer Handbook, 3rd Ed., J.Brandrup & E.H. Immergut, John Wiley and Sons, 1989, Ch. 2. Irradiation (e.g., e-beam or gamma irradiation) can also be used to generate PHA branching.

    [0074] The efficiency of branching and crosslinking of the polymer(s) can also be significantly enhanced by the dispersion of organic peroxides in a cross-linking agent, such as a polymerizable (i.e., reactive) plasticizers. The polymerizable plasticizer should contain a reactive functionality, such as a reactive unsaturated double bond, which increases the overall branching and crosslinking efficiency.

    [0075] As discussed above, when peroxides decompose, they form very high energy radicals that can extract a hydrogen atom from the polymer backbone. These radicals have short half-lives, thereby limiting the population of branched molecules that is produced during the active time period.

    ADDITIVES



    [0076] In certain embodiments, various additives are added to the compositions. Examples of these additives include antioxidants, slip/antiblock agents, pigments, UV stabilizers, fillers, plasticizers, nucleating agents, talc, wax, calcium carbonate, and radical scavengers. Additionally, polyfunctional branching agents such as divinyl benzene and trially cyanurate may be added. The branching agent and/or cross-linking agent is added to one or more of these for easier incorporation into the polymer. For instance, the branching agent and/or cross-linking agent is mixed with a plasticizer, e.g., a non-reactive plasticizer, e.g., a citric acid ester, and then compounded with the polymer under conditions to induce branching.

    [0077] Optionally, additives are included in the thermoplastic compositions at a concentration of about 0.05 to about 20% by weight of the total composition. For example, the range is certain embodiments is about 0.05 to about 5% of the total composition. The additive is any compound known to those of skill in the art to be useful in the production of thermoplastics. Exemplary additives include, e.g., plasticizers (e.g., to increase flexibility of a thermoplastic composition), antioxidants (e.g., to protect the thermoplastic composition from degradation by ozone or oxygen), ultraviolet stabilizers (e.g., to protect against weathering), lubricants (e.g., to reduce friction), pigments (e.g., to add color to the thermoplastic composition), flame retardants, fillers, reinforcing, mold release, and antistatic agents. It is well within the skilled practitioner's abilities to determine whether an additive should be included in a thermoplastic composition and, if so, what additive and the amount that should be added to the composition.

    [0078] The additive(s) can also be prepared as a masterbatch for example, by incorporating the additive(s) in a PHA blend and producing pellets of the resultant composition for addition to subsequent processing. In a masterbatch the concentration of the additive(s) is (are) higher than the final amount for the product to allow for proportionate mixing of the additive in the final composition.

    [0079] In poly-3-hydroxybutyrate compositions, for example, plasticizers are often used to change the glass transition temperature and modulus of the composition, but surfactants may also be used. Lubricants may also be used, e.g., in injection molding applications. Plasticizers, surfactants and lubricants may all therefore be included in the overall composition.

    [0080] In other embodiments, the blend includes one or more plasticizers. Examples of plasticizers include phthalic compounds (including dimethyl phthalate, diethyl phthalate, dibutyl phthalate, dihexyl phthalate, di-n-octyl phthalate, di-2-ethylhexyl phthalate, diisooctyl phthalate, dicapryl phthalate, dinonyl phthalate, diisononyl phthalate, didecyl phthalate, diundecyl phthalate, dilauryl phthalate, ditridecyl phthalate, dibenzyl phthalate, dicyclohexyl phthalate, butyl benzyl phthalate, octyl decyl phthalate, butyl octyl phthalate, octyl benzyl phthalate, n-hexyl n-decyl phthalate, n-octyl phthalate, and n-decyl phthalate), phosphoric compounds (including, but not limted to, tricresyl phosphate, trioctyl phosphate, triphenyl phosphate, octyl diphenyl phosphate, cresyl diphenyl phosphate, and trichloroethyl phosphate), adipic compounds (including dibutoxyethoxyethyl adipate (DBEEA), dioctyl adipate, diisooctyl adipate, di-n-octyl adipate, didecyl adipate, diisodecyl adipate, n-octyl n-decyl adipate, n-heptyl adipate, and n-nonyl adipate), sebacic compounds (including dibutyl sebacate, dioctyl sebacate, diisooctyl sebacate, and butyl benzyl sebacate), azelaic compounds, citric compounds (including triethyl citrate, acetyl triethyl citrate, tributyl citrate, acetyl tributyl citrate, and acetyl trioctyl citrate), glycolic compounds (including methyl phthalyl ethyl glycolate, ethyl phthalyl ethyl glycolate, and butyl phthalyl ethyl glycolate), trimellitic compounds (including trioctyl trimellitate and tri-n-octyl n-decyl trimellitate), phthalic isomer compounds (including dioctyl isophthalate and dioctyl terephthalate), ricinoleic compounds (including methyl acetyl, recinoleate and butyl acetyl recinoleate), polyester compounds (including reaction products of diols selected from butane diol, ethylene glycol, propane 1,2 diol, propane 1,3 diol, polyethylene glycol, glycerol, diacids selected from adipic acid, succinic acid, succinic anhydride and hydroxyacids such as hydroxystearic acid, epoxidized soy bean oil, chlorinated paraffins, chlorinated fatty acid esters, fatty acid compounds, plant oils, pigments, and acrylic compounds. The plasticizers may be used either alone respectively or in combinations with each other.

    [0081] In certain embodiments, the compositions and methods of the invention include one or more surfactants. Surfactants are generally used to de-dust, lubricate, reduce surface tension, and/or densify. Examples of surfactants include, but are not limited to mineral oil, castor oil, and soybean oil. One mineral oil surfactant is DRAKEOL® 34, available from Penreco (Dickinson, Texas, USA). MAXSPERSE® W-6000 and W-3000 solid surfactants are available from Chemax Polymer Additives (Piedmont, South Carolina, USA). Non-ionic surfactants with HLB values ranging from about 2 to about 16 can be used, examples being TWEEN-20, TWEEN-65, Span-40 and Span 85.

    [0082] Anionic surfactants include: aliphatic carboxylic acids such as lauric acid, myristic acid, palmitic acid, stearic acid, and oleic acid; fatty acid soaps such as sodium salts or potassium salts of the above aliphatic carboxylic acids; N-acyl-N-methylglycine salts, N-acyl-N-methyl-beta-alanine salts, N-acylglutamic acid salts, polyoxyethylene alkyl ether carboxylic acid salts, acylated peptides, alkylbenzenesulfonic acid salts, alkylnaphthalenesulfonic acid salts, naphthalenesulfonic acid salt-formalin polycondensation products, melaminesulfonic acid salt-formalin polycondensation products, dialkylsulfosuccinic acid ester salts, alkyl sulfosuccinate disalts, polyoxyethylene alkylsulfosuccinic acid disalts, alkylsulfoacetic acid salts, (alpha-olefinsulfonic acid salts, N-acylmethyltaurine salts, sodium dimethyl 5-sulfoisophthalate, sulfated oil, higher alcohol sulfuric acid ester salts, polyoxyethylene alkyl ether sulfuric acid salts, secondary higher alcohol ethoxysulfates, polyoxyethylene alkyl phenyl ether sulfuric acid salts, monoglysulfate, sulfuric acid ester salts of fatty acid alkylolamides, polyoxyethylene alkyl ether phosphoric acid salts, polyoxyethylene alkyl phenyl ether phosphoric acid salts, alkyl phosphoric acid salts, sodium alkylamine oxide bistridecylsulfosuccinates, sodium dioctylsulfosuccinate, sodium dihexylsulfosuccinate, sodium dicyclohexylsulfosuccinate, sodium diamylsulfosuccinate, sodium diisobutylsulfosuccinate, alkylamine guanidine polyoxyethanol, disodium sulfosuccinate ethoxylated alcohol half esters, disodium sulfosuccinate ethoxylated nonylphenol half esters, disodium isodecylsulfosuccinate, disodium N-octadecylsulfosuccinamide, tetrasodium N-(1,2-dicarboxyethyl)-N-octadecylsulfosuccinamide, disodium mono- or didodecyldiphenyl oxide disulfonates, sodium diisopropylnaphthalenesulfonate, and neutralized condensed products from sodium naphthalenesulfonate.

    [0083] One or more lubricants can also be added to the compositions and methods of the invention. Lubricants are normally used to reduce sticking to hot metal surfaces during processing and can include polyethylene, paraffin oils, and paraffin waxes in combination with metal stearates (e.g., zinc sterate). Other lubricants include stearic acid, amide waxes, ester waxes, metal carboxylates, and carboxylic acids. Lubricants are normally added to polymers in the range of about 0.1 percent to about 1 percent by weight, generally from about 0.7 percent to about 0.8 percent by weight of the compound. Solid lubricants is warmed and melted before or during processing of the blend.

    [0084] One or more anti-microbial agents can also be added to the compositions and methods of the invention. An anti-microbial is a substance that kills or inhibits the growth of microorganisms such as bacteria, fungi, or protozoans, as well as destroying viruses. Antimicrobial drugs either kill microbes (microbicidal) or prevent the growth of microbes (microbistatic). A wide range of chemical and natural compounds are used as antimicrobials, including but not limited to: organic acids, essential oils, cations and elements (e.g., colloidal silver). Commercial examples include PolySept® Z, UDA and AGION®.

    [0085] PolySept® Z (available from PolyChem Alloy) is a organic salt based, non-migratory antimicrobial. "UDA" is Urtica dioica agglutinin. AGION® antimicrobial is a silver compound. AMICAL® 48 is diiodomethyl p-tolyl sulfone. In certain aspects the antimicrobial agent slows down degradation of the composition.

    [0086] In film applications of the compositions and methods described herein, anti-lock masterbatch is also added. A suitable example is a slip anti-block masterbatch mixture of erucamide (20% by weight) diatomaceous earth (15% by weight) nucleant masterbatch (3% by weight), pelleted into PHA (62% by weight).

    CROSS-LINKING AGENTS



    [0087] Cross-linking agent, also referred to as co-agents, used in the methods and compositions of the invention are cross-linking agents comprising two or more reactive functional groups such as epoxides or double bonds. These cross-linking agents modify the properties of the polymer. These properties include, but are not limited to, melt strength or toughness. One type of cross-linking agent is an "epoxy functional compound." As used herein, "epoxy functional compound" is meant to include compounds with two or more epoxide groups capable of increasing the melt strength of polyhydroxyalkanoate polymers by branching, e.g., end branching as described above.

    [0088] When an epoxy functional compound is used as the cross-linking agent in the disclosed methods, a branching agent is optional. As such one embodiment of the invention is a method of branching a starting polyhydroxyalkanoate polymer (PHA), comprising reacting a starting PHA with an epoxy functional compound. Alternatively, the invention is a method of branching a starting polyhydroxyalkanoate polymer, comprising reacting a starting PHA, a branching agent and an epoxy functional compound. Alternatively, the invention is a method of branching a starting polyhydroxyalkanoate polymer, comprising reacting a starting PHA, and an epoxy functional compound in the absence of a branching agent. Such epoxy functional compounds can include epoxy-functional, styrene-acrylic polymers (such as, but not limited to, e.g., JONCRYL® ADR-4368 (BASF), or MP-40 (Kaneka)), acrylic and/or polyolefin copolymers and oligomers containing glycidyl groups incorporated as side chains (such as, but not limited to, e.g., LOTADER® (Arkema), poly(ethylene-glycidyl methacrylate-co-methacrylate)), and epoxidized oils (such as, but not limited to, e.g., epoxidized soybean, olive, linseed, palm, peanut, coconut, seaweed, cod liver oils, or mixtures thereof, e.g., Merginat® ESBO (Hobum, Hamburg, Germany) and EDENOL® B 316 (Cognis, Dusseldorf, Germany)).

    [0089] For example, reactive acrylics or functional acrylics cross-linking agents are used to increase the molecular weight of the polymer in the branched polymer compositions described herein. Such cross-linking agents are sold commercially. BASF, for instance, sells multiple compounds under the trade name "JONCRYL®," which are described in U.S. Pat. No. 6,984,694 to Blasius et al., "Oligomeric chain extenders for processing, post-processing and recycling of condensation polymers, synthesis, compositions and applications". One such compound is JONCRYL® ADR-4368CS, which is styrene glycidyl methacrylate and is discussed below. Another is MP-40 (Kaneka). And still another is Petra line from Honeywell, see for example, U.S. Patent No. 5,723,730. Such polymers are often used in plastic recycling (e.g., in recycling of polyethylene terephthalate) to increase the molecular weight (or to mimic the increase of molecular weight) of the polymer being recycled. Such polymers often have the general structure:

    R1 and R2 are H or alkyl

    R3 is alkyl

    x and y are 1-20

    z is 2-20



    [0090] E.I. du Pont de Nemours & Company sells multiple reactive compounds under the trade name Elvaloy®, which are ethylene copolymers, such as acrylate copolymers, elastomeric terpolymers, and other copolymers. One such compound is Elvaloy PTW, which is a copolymer of ethylene-n-butyl acrylate and glycidyl methacrylate. Omnova sells similar compounds under the trade names "SX64053," "SX64055," and "SX64056." Other entities also supply such compounds commercially.

    [0091] Specific polyfunctional polymeric compounds with reactive epoxy functional groups are the styrene-acrylic copolymers. These materials are based on oligomers with styrene and acrylate building blocks that have glycidyl groups incorporated as side chains. A high number of epoxy groups per oligomer chain are used, for example 5, greater than 10, or greater than 20. These polymeric materials generally have a molecular weight greater than 3000, specifically greater than 4000, and more specifically greater than 6000. These are commercially available from S.C. Johnson Polymer, LLC (now owned by BASF) under the trade name JONCRYL® ADR 4368 material. Other types of polyfunctional polymer materials with multiple epoxy groups are acrylic and/or polyolefin copolymers and oligomers containing glycidyl groups incorporated as side chains. A further example of such a polyfunctional carboxy-reactive material is a co- or ter-polymer including units of ethylene and glycidyl methacrylate (GMA), available under the trade name LOTADER® resin, sold by Arkema. These materials can further comprise methacrylate units that are not glycidyl. An example of this type is poly(ethylene-glycidyl methacrylate-co-methacrylate).

    [0092] Fatty acid esters or naturally occurring oils containing epoxy groups (epoxidized) can also be used. Examples of naturally occurring oils are olive oil, linseed oil, soybean oil, palm oil, peanut oil, coconut oil, seaweed oil, cod liver oil, or a mixture of these compounds. Particular preference is given to epoxidized soybean oil (e.g., Merginat® ESBO from Hobum, Hamburg, or EDENOL® B 316 from Cognis, Dusseldorf), but others may also be used.

    [0093] Another type of cross-linking agent are agents with two or more double bonds. Cross-linking agents with two or more double bond cross-link PHAs by after reacting at the double bonds. Examples of these include: diallyl phthalate, pentaerythritol tetraacrylate, trimethylolpropane triacrylate, pentaerythritol triacrylate, dipentaerythritol pentaacrylate, diethylene glycol dimethacrylate, bis(2-methacryloxyethyl)phosphate.

    [0094] In general, it appears that compounds with terminal epoxides may perform better than those with epoxide groups located elsewhere on the molecule.

    [0095] Compounds having a relatively high number of end groups are the most desirable. Molecular weight may also play a role in this regard, and compounds with higher numbers of end groups relative to their molecular weight (e.g., the JONCRYL®s are in the 3000 - 4000 g/mol range) are likely to perform better than compounds with fewer end groups relative to their molecular weight (e.g., the Omnova products have molecular weights in the 100,000-800,000 g/mol range).

    NUCLEATING AGENTS



    [0096] For instance, an optional nucleating agent is added to the composition to aid in its crystallization. Nucleating agents for various polymers are simple substances, metal compounds including composite oxides, for example, carbon black, calcium carbonate, synthesized silicic acid and salts, silica, zinc white, clay, kaolin, basic magnesium carbonate, mica, talc, quartz powder, diatomite, dolomite powder, titanium oxide, zinc oxide, antimony oxide, barium sulfate, calcium sulfate, alumina, calcium silicate, metal salts of organophosphates, and boron nitride; low-molecular organic compounds having a metal carboxylate group, for example, metal salts of such as octylic acid, toluic acid, heptanoic acid, pelargonic acid, lauric acid, myristic acid, palmitic acid, stearic acid, behenic acid, cerotic acid, montanic acid, melissic acid, benzoic acid, p-tert-butylbenzoic acid, terephthalic acid, terephthalic acid monomethyl ester, isophthalic acid, and isophthalic acid monomethyl ester; high-molecular organic compounds having a metal carboxylate group, for example, metal salts of such as: carboxyl-group-containing polyethylene obtained by oxidation of polyethylene; carboxyl-group-containing polypropylene obtained by oxidation of polypropylene; copolymers of olefins, such as ethylene, propylene and butene-1, with acrylic or methacrylic acid; copolymers of styrene with acrylic or methacrylic acid; copolymers of olefins with maleic anhydride; and copolymers of styrene with maleic anhydride; high-molecular organic compounds, for example: alpha-olefins branched at their 3-position carbon atom and having no fewer than 5 carbon atoms, such as 3,3 dimethylbutene-1,3-methylbutene-1,3-methylpentene-1,3-methylhexene-1, and 3,5,5-trimethylhexene-1; polymers of vinylcycloalkanes such as vinylcyclopentane, vinylcyclohexane, and vinylnorbornane; polyalkylene glycols such as polyethylene glycol and polypropylene glycol; poly(glycolic acid); cellulose; cellulose esters; and cellulose ethers; phosphoric or phosphorous acid and its metal salts, such as diphenyl phosphate, diphenyl phosphite, metal salts of bis(4-tert-butylphenyl) phosphate, and methylene bis-(2,4-tert-butylphenyl)phosphate; sorbitol derivatives such as bis(p-methylbenzylidene) sorbitol and bis(p-ethylbenzylidene) sorbitol; and thioglycolic anhydride, p-toluenesulfonic acid and its metal salts. The above nucleating agents may be used either alone or in combinations with each other. In particular embodiments, the nucleating agent is cyanuric acid. In certain embodiments, the nucleating agent can also be another polymer (e.g., polymeric nucleating agents such as PHB).

    [0097] In certain embodiments, the nucleating agent is selected from: cyanuric acid, carbon black, mica talc, silica, boron nitride, clay, calcium carbonate, synthesized silicic acid and salts, metal salts of organophosphates, and kaolin. In particular embodiments, the nucleating agent is cyanuric acid.

    [0098] In various embodiments, where the nucleating agent is dispersed in a liquid carrier, the liquid carrier is a plasticizer, e.g., a citric compound or an adipic compound, e.g., acetylcitrate tributyrate (Citroflex A4, Vertellus, Inc., High Point, N.C.), or DBEEA (dibutoxyethoxyethyl adipate), a surfactant, e.g., Triton X-100, TWEEN-20, TWEEN-65, Span-40 or Span 85, a lubricant, a volatile liquid, e.g., chloroform, heptane, or pentane, a organic liquid or water.

    [0099] In other embodiments, the nucleating agent is aluminum hydroxy diphosphate or a compound comprising a nitrogen-containing heteroaromatic core. The nitrogen-containing heteroaromatic core is pyridine, pyrimidine, pyrazine, pyridazine, triazine, or imidazole.

    [0100] In particular embodiments, the nucleating agent can include aluminum hydroxy diphosphate or a compound comprising a nitrogen-containing heteroaromatic core. The nitrogen-containing heteroaromatic core is pyridine, pyrimidine, pyrazine, pyridazine, triazine, or imidazole. The nucleant can have a chemical formula selected from the group consisting of

    and

    and combinations thereof, wherein each R1 is independently H, NR2R2, OR2, SR2, SOR2, SO2R2, CN, COR2, CO2R2, CONR2R2, NO2, F, Cl, Br, or I; and each R2 is independently H or C1-C6 alkyl.

    [0101] The nucleating agent can be a nucleating agent as described in U.S. Pat. App. Pub. 2005/0209377, by Allen Padwa.

    [0102] Another nucleating agent for use in the compositions and methods described herein are milled as described in WO 2009/129499 titled "Nucleating Agents for Polyhydroxyalkanoates," which was published in English. Briefly, the nucleating agent is milled in a liquid carrier until at least 5% of the cumulative solid volume of the nucleating agent exists as particles with a particle size of 5 µm (microns) or less. The liquid carrier allows the nucleating agent to be wet milled. In other embodiments, the nucleating agent is milled in liquid carrier until at least 10% of the cumulative solid volume, at least 20% of the cumulative solid volume, at least 30% or at least 40%-50% of the nucleating agent can exist as particles with a particle size of 5 µm (microns) or less, 2 µm (microns) or less or 1 µm (micron) or less. In alternative embodiments, the nucleating agents is milled by other methods, such as jet milling. Additionally, other methods is utilized that reduce the particle size.

    [0103] The cumulative solid volume of particles is the combined volume of the particles in dry form in the absence of any other substance. The cumulative solid volume of the particles is determined by determining the volume of the particles before dispersing them in a polymer or liquid carrier by, for example, pouring them dry into a graduated cylinder or other suitable device for measuring volume. Alternatively, cumulative solid volume is determined by light scattering.

    APPLICATION OF THE COMPOSITIONS



    [0104] For the fabrication of useful articles, the compositions described herein are processed preferably at a temperature above the crystalline melting point of the polymers but below the decomposition point of any of the ingredients (e.g., the additives described above, with the exception of some branching agents) of the polymeric composition. While in heat plasticized condition, the polymeric composition is processed into a desired shape, and subsequently cooled to set the shape and induce crystallization. Such shapes can include, but are not limited to, a fiber, filament, film, sheet, rod, tube, bottle, or other shape. Such processing is performed using any art-known technique, such as, but not limited to, extrusion, injection molding, compression molding, blowing or blow molding (e.g., blown film, blowing of foam), calendaring, rotational molding, casting (e.g., cast sheet, cast film), or thermoforming.

    [0105] The compositions are used to create, without limitation, a wide variety of useful products, e.g., automotive, consumer durable, construction, electrical, medical, and packaging products. For instance, the polymeric compositions is used to make, without limitation, films (e.g., packaging films, agricultural film, mulch film, erosion control, hay bale wrap, slit film, food wrap, pallet wrap, protective automobile and appliance wrap), golf tees, caps and closures, agricultural supports and stakes, paper and board coatings (e.g., for cups, plates and boxes), thermoformed products (e.g., trays, containers, lids, yoghurt pots, cup lids, plant pots, noodle bowls and moldings), housings (e.g., for electronics items, e.g., cell phones, PDA cases, music player cases and computer cases), bags (e.g., trash bags, grocery bags, food bags and compost bags), hygiene articles (e.g., diapers, feminine hygiene products, incontinence products and disposable wipes), coatings for pelleted products (e.g., pelleted fertilizer, herbicides, pesticides and seeds), injection molded articles (writing instruments, utensils and disk cases), solution and spun fibers and melt blown fabrics and non-wovens (threads, yarns, wipes, wadding, disposable absorbent articles), blow moldings (deep containers and bottles) and foamed articles (cups, bowls, plates and packaging).

    [0106] Thermoforming is a process that uses films or sheets of thermoplastic. The polymeric composition is processed into a film or sheet. The sheet of polymer is then placed in an oven and heated. When soft enough to be formed it is transferred to a mold and formed into a shape.

    [0107] During thermoforming, when the softening point of a semi-crystalline polymer is reached, the polymer sheet begins to sag. The window between softening and droop is usually narrow. It can therefore be difficult to move the softened polymer sheet to the mold quickly enough. Branching the polymer can be used to increase the melt strength of the polymer so that the sheet maintains is more readily processed and maintains its structural integrity. Measuring the sag of a sample piece of polymer when it is heated is therefore a way to measure the relative size of this processing window for thermoforming.

    [0108] Because the composition described herein have increased melt strength and increased processability, they are easier to convert to film or sheet form. They are therefore excellent candidates for thermoforming. Molded products include a number of different product types and, for example, including products such as disposable spoons, forks and knives, tubs, bowls, lids, cup lids, yogurt cups, and other containers, bottles and bottle-like containers, etc.

    [0109] The compositions described herein can be processed into films of varying thickness, for example, films of uniform thickness ranging from 10 -200 µm (microns), for example, 20-75 µm (microns), 75 to 150 µm (microns), or from 50-100 µm (microns). Film layers can additionally be stacked to form multilayer films of the same or varying thicknesses or compositions. For example, a film can comprise two, three, four or more layers, where the layers can include one or more layers of a composition of the invention combined with other polymer layers, such as PHA layers, or PLA layers.

    [0110] Blow molding, which is similar to thermoforming and is used to produce deep draw products such as bottles and similar products with deep interiors, also benefits from the increased elasticity and melt strength and reduced sag of the polymer compositions described herein.

    [0111] Articles made from the compositions can be annealed according to any of the methods disclosed in WO 2010/008445, and titled "Branched PHA Compositions, Methods For Their Production, And Use In Applications," which was filed in English.

    [0112] The compositions described herein are provided in any suitable form convenient for an intended application. For example, the composition is provided in pellet for subsequent production of films, coatings, moldings or other articles, or the films, coatings, moldings and other articles.

    [0113] The specific examples below are to be construed as merely illustrative, and not limitative of the remainder of the disclosure in any way whatsoever. Without further elaboration, it is believed that one skilled in the art can, based on the description herein, utilize the present invention to its fullest extent. All publications cited herein are hereby incorporated by reference in their entirety.

    EXAMPLES


    Experimental Methods


    Measurement of Torsional Melt Rheology (G')



    [0114] All oscillatory rheology measurements were performed using a TA Instruments AR2000 rheometer employing a strain amplitude of 1%. First, pellets (or powder) were molded into 25 mm diameter discs that were about 1200 µm (microns) in thickness. The disc specimens were molded in a compression molder set at about 165 °C, with the molding time of about 30 seconds. These molded discs were then placed in between the 25 mm parallel plates of the AR2000 rheometer, equilibrated at 180 °C, and subsequently cooled to 160 °C for the frequency sweep test. A gap of 800-900 µm (microns) was used, depending on the normal forces exerted by the polymer. The melt density of PHB was determined to be about 1.10 g/cm3 at 160 °C; this value was used in all the calculations.

    [0115] Specifically, the specimen disc is placed between the platens of the parallel plate rheometer set at 180 °C. After the final gap is attained, excess material from the sides of the platens is scraped. The specimen is then cooled to 160 °C where the frequency scan (from 625 rad/s to 0.10 rad/s) is then performed; frequencies lower than 0.1 rad/s are avoided because of considerable degradation over the long time it takes for these lower frequency measurements. The specimen loading, gap adjustment and excess trimming, all carried out with the platens set at 180 °C, takes about 2 ½ minutes. This is controlled to within ± 10 seconds to minimize variability and sample degradation. Cooling from 180 °C to 160 °C (test temperature) is accomplished in about four minutes. Exposure to 180 °C ensures a completely molten polymer, while testing at 160 °C ensures minimal degradation during measurement.

    [0116] During the frequency sweep performed at 160 °C, the following data are collected as a function of measurement frequency: |n*| or complex viscosity, G' or elastic modulus (elastic or solid-like contribution to the viscosity) and G" or loss modulus (viscous or liquid-like contribution to the viscosity). For purposes of simplicity, we will use G' measured at an imposed frequency of 0.25 rad/s as a measure of "melt strength". Higher G' translates to higher melt strength.

    Measurement of Capillary Stability



    [0117] The Capillary Stability was measured by performing steady shear experiments at 180 °C using a Kayness Galaxy V Capillary Rheometer. The die employed in the above capillary measurements was about 1.0 mm in diameter and about 30 mm in length. The capillary rheometer is a controlled shear rate device, and was operated at three shear rates (1,000 sec-1, 100 sec-1, and 10 sec-1), repeated three times, for a total of nine (9) data points collected over 17 minutes. The pellets (∼10 grams) were preheated at 180 °C for 240 seconds (4 minutes) before the start of the test. The nine test data points are collected without any delay between them.

    [0118] Because PHB copolymers undergo chain scission reactions in the melt that lead to a continuous decrease in melt viscosity as a function of time, the above test protocol generates data as shown below (see FIG. 1 for a representative PHB copolymer).

    [0119] When log (Apparent Viscosity) is plotted as a function of time, a systematic decrease in viscosity is evident; this trend is also noted to be quite linear. The slope of the "Apparent Viscosity Versus Time" fit yields is an indication of melt stability (according to ASTM D3835). In this report, we use this slope for data collected at a shear rate of 100 s-1 as an indication of melt stability and this slope is referred to as the "Capillary Stability".

    Measurement of Melt Crystallization



    [0120] A Perkin Elmer DSC is used to characterize the non-isothermal melt-crystallization kinetics of the subject PHB copolymers. In this test, the specimen (cut from a disc compression molded at 165 °C for one minute) is placed and crimped in the DSC sample pan. This test specimen is then exposed to 200 °C for one minute to melt all of the crystals; it is then cooled to 160 °C at 40 °C/min and maintained at 160 °C for about 1 minute. The specimen is then cooled to -50 °C at a rate of about 10 °C/min. As the polymer undergoes crystallization, an exothermic peak in the "heat flow versus temperature" trace becomes evident. The peak-temperature of this exotherm is noted as the crystallization temperature or Tmc. A higher Tmc generally means faster crystallization kinetics.

    Measurement of Mechanical Properties of Blown Film



    [0121] The Elmendorf resistance to tear propagation was measured according to ASTM D1922-06. The tear propagation resistance of the film was measured in two directions, along the flow exiting the die ("machine direction tear" or "MD Tear") and also perpendicular to the polymer flow exiting the die ("transverse direction tear" or "TD Tear").

    [0122] The dart impact strength was measured according to ASTM D1709-04.

    [0123] The tensile properties (i.e., modulus, strength, elongation to break) were measured according to ASTM D882-02.

    Measurement of the Mechanical Properties of Injection Molded Articles



    [0124] Tensile properties of injection molded articles were measured according to ASTM D638-03.

    [0125] Flexural properties of injection molded articles were measured according to ASTM D790-03.

    [0126] Notched Izod properties of injection molded articles were measured according to ASTM D256-06.

    Soil Biodegradation Test Method



    [0127] The biodegradation rate of the subject films was characterized and quantified using a soil burial test. In this test, a small piece of the film specimen (∼ 5 cm by 9 cm) was buried under 2.54 to 5.08 cm (1-2 inches) of soil in a plastic container inside a room where the temperature was maintained between 20-25°C. The soil was a top soil obtained from a local commercial vegetable farm in Massachusetts. The soil moisture content was maintained by watering regularly (7 grams of water was added to about 100 grams of soil once every three days). Since the container was not covered, the moisture content in the soil dropped from about 9-10% to 1-2% in three days. The buried film specimens are retrieved on a weekly basis (different specimen for each week of elapsed time buried in soil); the retrieved specimens are first washed with water to remove dirt and then dried with paper towels. The dried film specimens (or fragments, if considerable biodegradation had already occurred) are weighed. The measured weight loss quantifies the rate of biodegradation for the different formulations. In Examples presented in this application, the film specimen geometry is kept constant; consequently, the absolute value of the weight loss provides an accurate depiction of the biodegradation kinetics. A higher weight loss translates to faster biodegradation.

    Example 1. Compositions Containing PHA Blends and Poly(Butylene Succinate)



    [0128] In this Example, which is not part of the invention, compositions that include a PHA copolymer and PBS (BIONOLLE® 1001 from Showa Highpolymer Co., Ltd., Japan) were prepared by dry-blending the components at a pre-determined ratio and subjecting this mixture to twin-screw extrusion in a 1.905 cm (¾ inch) Brabender extruder operated at about 50 rpm and a melt temperature of about 180 °C. The formulations are indicated in the table below.
    Table 1. Compositions containing PHA blend and PBS
    Formulation123456789
    PHA Blend (wt%) 97 92 87 77 62 47 32 17 0
    Nuc.MB (wt%) 3 3 3 3 3 3 3 3 0
    PBS (wt%) 0 5 10 20 35 50 65 80 100
    Total 100 100 100 100 100 100 100 100 100
    Data: G'(@ 0.25 rad/s) 51 74 48 103 170 202 363 659 1288
    Eta* (@ 0.25 rad/s) 2937 3122 2517 2846 3761 4179 5119 7081 1292 0
    Capillary Stability -0.10 -0.08 -0.08 -0.09 -0.08 -0.10 -0.09 -0.06 -0.02
    Tmc (PHA Blend) 113.4 107. 9 108. 2 107.9 103.2 100.4 102.0 99.1 -
    Tmc (PBS) - nd nd nd 85.6 85.3 87.2 86.2 87.1
    "nd" = not detectable


    [0129] The PHA blend was composed of about 58-62% homo-polymer of 3-hydroxybutanoic acid, and about 38-42% copolymer of 3-hydroxybutanoic acid and 4-hydroxybutanoic acid, where the 4-hydroxybutanoic acid is approximately 8-14% weight percent. The nucleating masterbatch ("Nuc. MB") was cyanuric acid that had been previously compounded at a rate of 33% (by weight) into a base resin of 3-hydroxybutanoic acid and 4-hydroxybutanoic acid, and pelleted. The PBS was BIONOLLE® 1001 (Showa Highpolymer Co., Ltd., Japan).

    [0130] Formulation 1 is the PHA control (no PBS). Formulation 2 is the PBS control (no PHA blend). The PHA control displays considerably lower melt viscosity (Eta*) and melt strength (G') compared to PBS. The melt stability (capillary stability) of the PHA is also worse compared to that of PBS. G' and capillary stability for the formulations are plotted as a function of formulation composition below. These parameters appear to be quite independent of formulation composition when PBS is the minor component and strongly dependent on formulation composition when PBS is the major component. In other words, the increase in G' with increasing levels of the higher melt strength PBS in the blend is very modest up to a formulation composition of about 50 % PBS. As the concentration of PBS in these formulations is increased further, the increase in G' becomes significant as it approaches the G' of the pure PBS. In terms of capillary stability, PBS is considerably more stable compared to the pure PHA. The capillary stability of all formulations with PHA as the major component is very similar to that of the PHA control; however, when PBS becomes the major component, a systematic improvement in stability is evident with increasing levels of PBS. The crystallization rate (Tmc) of PHA decreases slightly in the presence of PBS; however, Tmc does not appear to depend on PBS concentration. All of the data for this particular formulation series indicate a multi-phase melt with very little miscibility between the PHA and PBS. See FIG. 2 and FIG. 3.

    Example 2. Compositions Containing PHA Blends and Polybutylene Succinate Adipate



    [0131] In this Example, formulations of a PHA copolymer and PBSA (BIONOLLE® 3001 from Showa Highpolymer Co., Ltd., Japan) were prepared by dry-blending the components at a pre-determined ratio and subjecting this mixture to twin-screw extrusion in a 1.905 cm (¾ inch) Brabender extruder operated at about 50 rpm and a melt temperature of about 180 °C. The compositions of the formulations are indicated in the table below.
    Table 2. Compositions containing PHA blend and PBSA
    Formulation123456789
    PHABlend (wt%) 97 92 87 77 62 47 32 17 0
    Nuc.MB (wt%) 3 3 3 3 3 3 3 3 0
    PBSA (wt%) 0 5 10 20 35 50 65 80 100
    Total 100 100 100 100 100 100 100 100 100
    Data:         
    G' (@ 0.25 rad/s) 51 64 72 108 133 133 300 1009 1383
                       
    Eta* (@ 0.25 rad/s) 2937 2931 2834 2787 3274 3392 4902 9284 13560
    Capillary Stability -0.10 -0.10 -0.09 -0.09 -0.11 -0.11 -0.08 -0.04 -0.02
    Tmc (PHA Blend) 113.4 108.4 109.0 107.3 103.6 103.0 100.0 nd -
    Tmc (PBSA) - nd nd nd 65.0 63.3 62.3 62.3 65.0
    "nd" = not detectable


    [0132] The PHA blend was composed of about 58-62% homo-polymer of 3-hydroxybutanoic acid, and about 38-42% co-polymer of 3-hydroxybutanoic acid and 4-hydroxybutanoic acid, where the 4-hydroxybutanoic acid is approximately 8-14% weight percent. The nucleating masterbatch ("Nuc. MB") was cyanuric acid that had been previously compounded at a rate of 33% (by weight) into a base resin of 3-hydroxybutanoic acid and 4-hydroxybutanoic acid, and pelleted. The PBSA was BIONOLLE® 3001 (Showa Highpolymer Co., Ltd., Japan).

    [0133] Formulation 1 is the PHA control (no PBSA). Formulation 9 is the PBSA control (no PHA Blend). The PHA control displays considerably lower melt viscosity and melt strength compared to PBSA. The melt stability of the PHA is also worse compared to that of PBSA. G' and capillary stability for the formulations are plotted as a function of formulation composition below. These parameters appear to be quite independent of formulation composition when PBSA is the minor component and strongly dependent on formulation composition when PBSA is the major component. In other words, the increase in G' with increasing levels of the higher melt strength PBSA in the formulation is very modest up to a formulation composition of about 50 % PBSA. As the concentration of PBSA in these formulations is increased further, the increase in G' becomes significant as it approaches the G' of the pure PBSA. In terms of capillary stability, PBSA is considerably more stable compared to the pure PHA. The capillary stability of all formulations with PHA as the major component is very similar to that of the PHA control; however, when PBSA becomes the major component, a systematic improvement in stability is evident with increasing levels of PBSA. The crystallization rate (Tmc) of PHA decreases slightly in the presence of PBSA; however, Tmc does not appear to depend on PBSA concentration. All of the data for this particular formulation series indicate a multi-phase melt with very little miscibility between the PHA and PBSA. Finally, formulations of PHA with PBS behaved quite similar to formulations of PHA and PBSA. See FIG. 4 and FIG. 5.

    Example 3. Compositions Containing PHA Blends and PBS Combined With Organic Peroxide



    [0134] In Examples 1 and 2, blends of PHA with either PBS or PBSA were prepared using simple melt-extrusion. The melt rheology of these formulations indicated the existence of two distinct phases in the melt, with the rheological signature of the major formulation component dominating the overall response. In this example, which is not part of the invention, blends of PHA with PBS are presented, where the melt-blending was carried out in the presence of an organic peroxide. A common plasticizer, CITROFLEX® A4, was also included in these formulations. All of the components for each formulation were physically mixed at a pre-determined ratio, and this mixture was then subjected to twin-screw extrusion in a 1.905 cm (¾"-inch) Brabender extruder operated at about 50 rpm and a melt temperature of about 180 °C. The formulation compositions are indicated in the table below.
    Table 3. Compositions containing PHA blend, PBS and organic peroxide
    Formulation12
    PHA Blend (wt%) 72 72
    Nuc.MB (wt%) 3 3
    Citroflex A4 5 4.8
    Peroxide (wt%) 0 0.2
    PBS (wt%) 20 20
    Total 100 100
    Data:  
    G' (@ 0.25 rad/s) 148 865
    Eta* (@ 0.25 rad/s) 3380 7342
    Capillary Stability 00.14 - 0.12
    Tmc (PHA Blend) 103.1 105.0
    Tmc (PBS) 84.0 85.7


    [0135] The PHA blend was composed of about 58-62% homo-polymer of 3-hydroxybutanoic acid, and about 38-42% co-polymer of 3-hydroxybutanoic acid and 4-hydroxybutanoic acid, where the 4-hydroxybutanoic acid is approximately 8-14% weight percent. The nucleating masterbatch ("Nuc. MB") was cyanuric acid that had been previously compounded at a rate of 33% (by weight) into a base resin of 3-hydroxybutanoic acid and 4-hydroxybutanoic acid, and pelleted. The peroxide was tert-butylperoxy-2-ethylhexylcarbonate (available from Akzo Nobel as TRIGANOX® 117). The PBS was BIONOLLE® 1001 (Showa Highpolymer Co., Ltd., Japan).

    [0136] Formulation 1 is the first control with about 20 weight percent PBS. Formulation 2 is similar in composition to Formulation 1 with the exception of about 0.2 percent of an organic peroxide (TRIGANOX® 117) pre-dissolved in CITROFLEX® A4 prior to the mixing of the formulation components. Formulation 2 displays considerably higher melt strength (G') and better melt stability (smaller capillary stability) compared to Formulation 1; further, the PHA and PBS appear to crystallize at higher temperatures in formulations prepared with peroxide. The melt rheology (complex viscosity versus angular frequency) for Formulation 1 and 2 are shown in FIG. 6; the data for the corresponding PHA control (Formulation 1 from Examples 1 and 2) and the PBS are also. In this figure, the control formulation for this example, Formulation 1, shows rheological behavior very similar to that of the PHA control. However, the rheological signature of Formulation 2 appeared to be in between those of the PHA control and the PBS control. In other words, the formulation prepared using reactive extrusion (in the presence of an organic peroxide) showed rheological characteristics intermediate to those of the PHA and PBS controls. See FIG. 6.

    Example 4. Compositions Containing PHA Blends and PBSA Combined With Organic Peroxide



    [0137] This example is very similar to Example 3, except that PBSA (BIONOLLE® 3001) was used in place of PBS (BIONOLLE® 1001).
    Table 4. Compositions containing PHA blend, PBSA and organic peroxide
    Formulation12
    PHA Blend (wt%) 72 72
    Nuc.MB (wt%) 3 3
    Citroflex A4 5 4.8
    Peroxide (wt%) 0 0.2
    PBSA (wt%) 20 20
    Total 100 100
    Data:    
    G' (@ 0.25 rad/s) 105 398
    Eta* (@ 0.25 rad/s) 3080 4659
    Capillary Stability 00.14 - 0.11
    Tmc (PHA Blend) 106.0 107.3
    Tmc (PBSA) nd nd
    "nd" = not detectable


    [0138] The PHA blend was composed of about 58-62% homo-polymer of 3-hydroxybutanoic acid, and about 38-42% co-polymer of 3-hydroxybutanoic acid and 4-hydroxybutanoic acid, where the 4-hydroxybutanoic acid is approximately 8-14% weight percent. The nucleating masterbatch ("Nuc. MB") was cyanuric acid that had been previously compounded at a rate of 33% (by weight) into a base resin of 3-hydroxybutanoic acid and 4-hydroxybutanoic acid, and pelleted. The peroxide was tert-butylperoxy-2-ethylhexylcarbonate (available from Akzo Nobel as TRIGANOX® 117). The PBSA was BIONOLLE® 3001 (Showa Highpolymer Co., Ltd., Japan).

    [0139] In Examples 1 and 2, blends of PHA with either PBS or PBSA were prepared using simple melt-extrusion. The melt rheology of these formulations indicated the existence of two distinct phases in the melt, with the rheological signature of the major formulation component dominating the overall response. In this example, combinations of PHA with PBSA are presented wherein the melt-blending was carried out in the presence of an organic peroxide. A common plasticizer, CITROFLEX® A4, was also included in these formulations. All of the components for each formulation were physically mixed at a pre-determined ratio; this mixture was subjected to twin-screw extrusion in a 1.905 cm (¾ inch) Brabender extruder operated at about 50 rpm and a melt temperature of about 180 °C. The compositions are indicated in the table above. Formulation 1 is the first control with about 20 weight percent PBSA. Formulation 2 is similar in composition to Formulation 1 with the exception of about 0.2 percent of an organic peroxide (TRIGANOX® 117) pre-dissolved in CITROFLEX® A4prior to the mixing of the formulation components. Formulation 2 displays considerably higher melt strength (G') and better melt stability (smaller capillary stability) compared to Formulation 1; further, the PHA crystallizes at higher temperature in formulations prepared with peroxide.

    [0140] The observations presented in this Example are largely similar to those presented in Example 3. In summary, when PHA/PBSA formulations are prepared by simple melt-extrusion, their melt rheology suggest a multi-phase melt with the major formulation component dominating the response on a rheological length scale. In contrast, when the same formulations are prepared using reactive melt-extrusion, the rheological response indicate a single-phase melt with some unexpected benefits in melt strength and melt stability. The PHA phase also crystallizes at a higher temperature when the formulation is prepared using reactive extrusion.

    [0141] Examples 3 and 4 show the distinct melt rheological advantages (higher melt strength and superior melt stability) when blends of PHA and PBS or PBSA are created using reactive melt-extrusion in the presence of very small amounts of an organic peroxide. The improvements noted in melt strength and capillary stability (melt stability) are unexpected and very advantageous (melt properties for making films and related material).
    Reactive melt extrusion is studied further in the subsequent examples.

    Example 5. Films Containing PHA/PBSA Blends Melt-Compounded in the Presence of an Organic Peroxide



    [0142] In Examples 1 and 2, the characteristics of PHA/PBS and PHA/PBSA formulations prepared by simple melt-blending were discussed. The melt rheology of these formulations indicated poor miscibility between the two polymers with the rheology of the major component dominating the overall response. In Examples 3 and 4, it was shown that when PHA/PBS and PHA/PBSA formulations are prepared by melt-blending in the presence of a reactive compound such as an organic peroxide, some synergistic rheological observations are evident. These formulations, created in a reactive environment, displayed considerably higher melt strength and better melt stability compared to formulations created without peroxide; the PHA phase also crystallizes at a higher temperature in these formulations.

    [0143] The present example is an extension of Example 4, wherein a different PHA is melt-compounded with PBSA in the presence of an organic peroxide and a branching co-agent. The relative proportions of the PHA and PBSA phases were varied while all other additives (plasticizer, mineral fillers) were kept unchanged. The compositions are described in table below. These compositions were created using a 27 mm MAXX Leistritz co-rotating twin-screw extruder with the 10 barrel and die zones set at 175 / 175 / 170 / 170 / 170 / 165 / 165 / 165 / 160 / 160 (°C). Other compounding data and conditions are also listed in the table.
    Table 5. Compositions containing PHA blend, PBSA and organic peroxide
    Formulation1234PBSA
    PHA Blend (wt%) 79 71 59 47  
    PBSA (wt%) 0 8 20 32  
    Nuc.MB (wt%) 3 3 3 3  
    Slip/Antiblock MB (wt%) 5 5 5 5  
    Citroflex A4 (wt%) 7.75 7.75 7.75 7.75  
    Peroxide (wt%) 0.15 0.15 0.15 0.15  
    PE3A (wt%) 0.10 0.10 0.10 0.10  
    CaCO3 (wt%) 5 5 5 5  
    Total 100 100 100 100  
    Compounding Data:     
    Screw RPM 125 125 150 150  
    Rate (lbs/hr) 85 85 75 75  
    Melt Temp (°C) 189 196 204 209  
    Melt Pressure (psi) 2321 2395 2530 2649  
    Load (%) 46 46 40 41  
    Data:     
    G' (@ 0.25 rad/s) 549 689 1413 2584 1383
    Eta* (@ 0.25 rad/s) 6975 7380 8749 13420 13560
    Capillary Stability -0.09 -0.08 -0.06 -0.06 -0.02
    Tmc (PHA Blend) 105.9 103.4 101.8 99.1 -
    Tmc (PBSA) - nd 60.2 64.3 65.0
    Film MD Tear (g) 18.2 32.8 38 39.4 24
    Film TD Tear (g) 29.8 36 42 45.6 32
    Film Dart Impact (g) 25 52 59 70 200
    Film MD Modulus (MPa) 395 369 359 306 320
    Film MD Break Strength (MPa) 18.5 21.8 23 22.8 40.0
    Soil Biodegradation (Wt loss after 5 weeks (grams)) 0.207 0.117 0.085 0.054 0.031


    [0144] The PHA blend was composed of about 34-38% homo-polymer of 3-hydroxybutanoic acid, and about 22-26% co-polymer of 3-hydroxybutanoic acid and 4-hydroxybutanoic acid, where the 4-hydroxybutanoic acid is approximately 8-14 weight percent, and about 38-42% co-polymer of 3-hydroxybutanoic acid and 4-hydroxybutanoic acid with the 4-hydroxybutanoic acid composition being nominally 25-33 weight percent. The nucleating masterbatch ("Nuc. MB") was cyanuric acid that had been previously compounded at a rate of 33% (by weight) into a base resin of 3-hydroxybutanoic acid and 4-hydroxybutanoic acid, and pelleted. The slip anti-block masterbatch was a mixture of erucamide (20% by weight) diatomaceous earth (15% by weight) nucleant masterbatch (3% by weight), pelleted into PHA (62% by weight). The peroxide was tert-butylperoxy-2-ethylhexylcarbonate (available from Akzo Nobel as TRIGANOX® 117). The PBSA was BIONOLLE® 3001 (Showa Highpolymer Co., Ltd., Japan). "PE3A" is pentaerythritol triacrylate. The CaCO3 was calcium carbonate (EMFORCE® Bio, available from (Specialty Minerals Inc., Bethlehem, PA, USA).

    [0145] The table above lists the measured properties for the various formulations prepared. Formulation 1 is the control sample without any PBSA, while Formulations 2, 3, and 4 contain 8, 20 and 32 weight percent PBSA in the formulation. In FIG. 8, G' and capillary stability are shown as a function of composition for the samples from this example and for samples from Example 2 (non-reactive formulation counterparts). The advantages of combining in the presence of a reactive compound are distinct and surprising. The melt strength and melt stability are considerably superior for formulations created using reactive extrusion. In fact, both G' and capillary stability for these formulations are statistically better than what one might predict using a simple rule-of-mixtures trend. See FIG. 7 and FIG. 8.

    [0146] The blends from this example (including pure PBSA) were also converted into blown film for further characterization. The blown films were made using a 3.81 cm (1.5 inch) 24:1 Davis Standard extruder fitted with a 6.35 cm (2.5 inch) spiral mandrel die and a Future Design dual-lip air ring. The temperature setting on the extruder was 176.7 / 173.9 / 171.1 / 165.6 (°C) (350 / 345 / 340 / 330 (°F)) and the die was set at 168.3 °C (335 °F). The extruder was operated at 40 rpm with a die gap setting of about 1.016 mm (40 mils). The films collected were about 50.8 µm (2 mils) in thickness at a blow-up ratio of about 2.5.

    [0147] The film properties, particularly tear resistance, of the PHA/PBSA formulations created using reactive extrusion are considerably better than that of the PHA control and the PBSA control. This is another synergistic observation from such reactive blends. Another advantage of blending PBSA with PHA is the considerably slower rate of biodegradation of the resultant films relative to the PHA control. The soil biodegradation results for the reactive blend films, after 5 weeks in soil, show considerably lower weight loss compared to the control film.

    Example 6. Films Containing PHA Blends and PBS Combined With Organic Peroxide



    [0148] This example, which is not part of the invention, is largely similar to Example 5 and is somewhat of an extension to Example 3. Here, a different PHA is melt-compounded with PBS in the presence of an organic peroxide and a branching co-agent. The relative proportions of the PHA and PBS phases were varied while all other additives (plasticizer, mineral fillers) were kept unchanged. The compositions of these formulations are described in table below. These formulations were created using a 27 mm MAXX Leistritz co-rotating twin-screw extruder with the 10 barrel and die zones set at 175 / 175 / 170 / 170 / 170 / 165 / 165 / 165 / 160 / 160 (°C). Other compounding data and conditions are also listed in the table.
    Table 6. Compositions containing PHA blend, PBS and organic peroxide
    Formulation1234PBSA
    PHA Blend (wt%) 79 71 59 47  
    PBS (wt%) 0 8 20 32  
    Nuc.MB (wt%) 3 3 3 3  
    Slip/Antiblock MB (wt%) 5 5 5 5  
    CITROFLEX® A4 (wt%) 7.75 7.75 7.75 7.75  
    Peroxide (wt%) 0.15 0.15 0.15 0.15  
    PE3A (wt%) 0.10 0.10 0.10 0.10  
    CaCO3 (wt%) 5 5 5 5  
    Total 100 100 100 100  
    Compounding Data:     
    Screw RPM 125 125 150 150  
    Rate (lbs/hr) 85 85 75 75  
    Melt Temp (°C) 189 195 202 209  
    Melt Pressure (psi) 2321 2415 2579 2632  
    Load (%) 46 46 40 41  
    Data:     
    G' (@ 0.25 rad/s) 549 785 1390 2950 1288
    Eta* (@ 0.25 rad/s) 6975 7818 9002 15020 12920
    Capillary Stability -0.09 -0.08 -0.06 -0.06 -0.02
    Tmc (PHA Blend) 105.9 101.5 100.5 100.0 -
    Tmc (PBS) - nd 83.2 86.7 87.1
    Film MD Tear (g) 18.2 24.8 34 34.2 -
    Film TD Tear (g) 29.8 32 38.4 34.8 -
    Film Dart Impact (g) 25 46 63 49 -
    Film MD Modulus (MPa) 395 407 391 362 -
    Film MD Break Strength (MPa) 18.5 17.2 23 26.4 -
    Soil Biodegradation (Wt loss after 5 weeks (grams)) 0.207 0.115 0.075 0.049 -
    "nd" = not detectable


    [0149] The PHA blend was composed of about 34-38% homo-polymer of 3-hydroxybutanoic acid, and about 22-26% co-polymer of 3-hydroxybutanoic acid and 4-hydroxybutanoic acid, where the 4-hydroxybutanoic acid is approximately 8-14 weight percent, and about 38-42% co-polymer of 3-hydroxybutanoic acid and 4-hydroxybutanoic acid with the 4-hydroxybutanoic acid composition being nominally 25-33 weight percent. The nucleating masterbatch ("Nuc. MB") was cyanuric acid that had been previously compounded at a rate of 33% (by weight) into a base resin of 3-hydroxybutanoic acid and 4-hydroxybutanoic acid, and pelleted. The slip anti-block masterbatch was a mixture of erucamide (20% by weight) diatomaceous earth (15% by weight) nucleant masterbatch (3% by weight), pelleted into PHA (62% by weight). The peroxide was tert-butylperoxy-2-ethylhexylcarbonate (available from Akzo Nobel as TRIGANOX® 117). The PBS was BIONOLLE® 1000 (Showa Highpolymer Co., Ltd., Japan). "PE3A" is pentaerythritol triacrylate. The CaCO3 was calcium carbonate (EMFORCE® Bio, available from (Specialty Minerals Inc., Bethlehem, PA, USA).

    [0150] The table above lists the measured properties for the various formulations prepared. Formulation 1 is the control sample without any PBS, while Formulation 2, 3, and 4 contain 8, 20 and 32 weight percent PBS in the formulation. Similar to the observations for Example 5, the advantages of combining in the presence of a reactive compound are distinct and surprising. The melt strength and melt stability are considerably superior for the formulations created using reactive extrusion, much better than a rule-of-mixtures prediction.

    [0151] The formulations from this example were also converted into blown film for further characterization. The blown films were made using a 3.81 cm (1.5 inch) 24:1 Davis Standard extruder fitted with a 6.35 cm (2.5 inch) spiral mandrel die and a Future Design dual-lip air ring. The temperature setting on the extruder was 176.7 / 173.9 / 171.1 / 165.6 (°C) (350 / 345 / 340 / 330 (°F)) and the die was set at 168.3 °C (335 °F). The extruder was operated at 40 rpm with a die gap setting of about 1.016 mm (40 mils). The films collected were about 50.8 µm (2 mils) in thickness at a blow-up ratio of about 2.5.

    [0152] The film properties, particularly tear resistance and dart impact resistance, of the PHA/PBS formulations created using reactive extrusion are considerably better than that of the PHA control. Another advantage of combining PBS with PHA is the considerably slower rate of biodegradation of the resultant films relative to the PHA control. The soil biodegradation results for the reactive formulation films, after 5 weeks in soil, show considerably lower weight loss compared to the control film.

    Example 7. Injection Molded Articles Containing PHA Blends and PBS



    [0153] In this example, PHA blend injection molding formulations were made that also included PBS. The formulations began with production of an injection molding composition containing PHA Blend 73% by weight, Acrawax C concentrate (50% active) 1% by weight, talc 11% by weight (FLEXTALC® 610D, available from Specialty Minerals Inc., Bethlehem, PA, USA), calcium carbonate 10% by weight (MULTIFEX-MM®, available from Specialty Minerals Inc., Bethlehem, PA, USA), and nucleating masterbatch 5% by weight. The PHA blend was composed of about 58-62% homo-polymer of 3-hydroxybutanoic acid, and about 38-42% co-polymer of 3-hydroxybutanoic acid and 4-hydroxybutanoic acid, where the 4-hydroxybutanoic acid is approximately 8-14% weight percent. The nucleating agent is cyanuric acid dispersed at a rate of 33% (by weight) in CITROFLEX® A4 plasticizer and milled.

    [0154] This injection molding composition was then dry-blended with PBS, or with PBS and peroxide. The peroxide was tert-butylperoxy-2-ethylhexylcarbonate (available from Akzo Nobel as TRIGANOX® 117). The PBS was BIONOLLE® 1001 (Showa Highpolymer Co., Ltd., Japan). The formulations are shown in the table below.
    Table 7. Compositions containing PHA blend, PBS and organic peroxide
    Formulation123
    IM Composition (wt%) 100 70 69.9
    PBS (wt%) 0 30 30
    Peroxide (wt%) 0 0 0.1
    Total 100 100 100
    Compounding:   
    Pressure (psi) 1708 1589 3028
    Load (%) 45 39 48
    Melt Temp (°C) 203 202 211
    Data:   
    Tensile Strength (Mpa) 25.68 27.52 29.41
    Tensile Modulus (Mpa) 2765 1775 1747
    Tensile Elongation (%) 4.07 11.49 17.41
    Flexural Strength (Mpa) 46.14 40.03 41.07
    Flexural Modulus (Mpa) 2872 1853 1832
    Notched Izod Impact Strength (ft-lb/in) 0.528 0.735 0.859
    Onset Crystallization Temperature (°C) 118.4 107.4 109.6
    Peak Crystallization Temperature (°C) 113.89 103.81 105.49
    Zero Time Melt Viscosity, 100 s-1 (Pa.s) 1447 1534 1919
    Five Minute Melt Viscosity, 100 s-1 (Pa.s) 894 1186 1523
    Melt Stability (min-1) -0.0962 -0.0515 -0.0462
    G' (0.25 rad/s) (Pa) 115.9 1712 7887
    Eta * (0.25 rad/s) (Pa.s) 3540 15200 37140


    [0155] The above formulations were compounded using a 27 mm Leistritz twin-screw extruder using the following temp-profile: 175 / 175 / 175 / 175 / 170 / 170 / 170 / 170 / 170 / 180 (°C); the formulations were made at 27.22 kg/hr (60 lbs/hr) rate and 125 screw rpm.

    [0156] All tensile properties were measured according to ASTM D638-03. All flexural properties were measured according to ASTM D790-03. Notched Izod impact strength was measured according to D256-06.

    [0157] As shown above, tensile strength, tensile elongation and notched Izod were improved by addition of PBS, especially when melt-blended in the presence of a reactive compound, but tensile modulus, and flexural modulus and strength were negatively affected.

    [0158] Melt stability, G' and Eta* were also greatly improved by addition of PBS, especially when melt-blended in the presence of a reactive compound.

    [0159] The table above summarizes the melt rheology of the compounded pellets and the mechanical properties of injection molded bars from the above formulations. The advantages of combining PBS with PHA blends in the presence of peroxide are distinct as evident in G', melt capillary stability, tensile strength, tensile elongation and impact strength.

    Example 8. Injection Molded Articles Containing PHA Blends and PBS



    [0160] In this example, which is not part of the invention, a slightly different injection molding composition was combined with PBS.

    [0161] The formulations began with production of an injection molding composition containing PHA Blend 73.21% by weight, Acrawax C concentrate (50% active) 0.36% by weight, talc 11.66% by weight (FLEXTALC® 610D, available from Specialty Minerals Inc., Bethlehem, PA, USA), calcium carbonate 10.2% by weight (EMFORCE® Bio, available from Specialty Minerals Inc., Bethlehem, PA, USA), and nucleating masterbatch 4.57% by weight. The PHA blend was composed of about 58-62% homo-polymer of 3-hydroxybutanoic acid, and about 38-42% co-polymer of 3-hydroxybutanoic acid and 4-hydroxybutanoic acid, where the 4-hydroxybutanoic acid is approximately 8-14% weight percent. The nucleating agent is cyanuric acid dispersed at a rate of 33% (by weight) in CITROFLEX® A4 plasticizer and milled.

    [0162] This injection molding composition was compounded and then dry-blended with PBS. The PBS was BIONOLLE® 1001 (Showa Highpolymer Co., Ltd., Japan). The formulations are shown in the table below.
    Table 8. Compositions containing PHA blend and PBS
    Formulation1234
    IM Composition (wt%) 100 90 80 50
    PBS (wt%) 0 10 20 50
    Total 100 100 100 100
    Data:    
    Tensile Strength (Mpa) 27.1 26.5 27.4 33.0
    Tensile Modulus (Mpa) 2915 2249 1959 1322
    Tensile Elongation (%) 5.4 5.6 7.6 19.9
    Flexural Strength (Mpa) 36.1 41.6 39.8 36.1
    Flexural Modulus (Mpa) 2748 2197 1879 1306
    Notched Izod Impact Strength (ft-lb/in) 0.577 0.601 0.729 0.989
    Onset Crystallization Temperature (°C) 118.29 114.22 115.16 111.21
    Peak Crystallization Temperature (°C) 113.82 110.19 111.21 106.33


    [0163] As shown above, the addition of PBS caused a decrease in the flexural and tensile modulus, but caused an increase in tensile strength, tensile elongation, and notched impact strength. The peak crystallization temperature was also decreased.

    [0164] Addition of PBS also appeared to decrease the level of flash seen in injection molded test bars, as shown in FIG. 9.

    Example 9. Extruded Films Containing PBS or PBSA.



    [0165] In this example, extruded films were made and tested for biodegradability. The following PHA formulation was made.
    Table 9. PHA Formulation for Extruded Film
    IngredientWt %
    PHA Blend 78.00
    Nucleating Masterbatch 3.00
    Calcium Carbonate 5.00
    Slip Antiblock Masterbatch 5.00
    CITROFLEX® A4 plasticizer 8.73
    Peroxide 0.18
    PE3A 0.09


    [0166] The PHA blend was composed of about 10-14% homo-polymer of 3-hydroxybutanoic acid, and about 46-50% co-polymer of 3-hydroxybutanoic acid and 4-hydroxybutanoic acid, where the 4-hydroxybutanoic acid is approximately 8-14 weight percent, and about 38-42% co-polymer of 3-hydroxybutanoic acid and 4-hydroxybutanoic acid with the 4-hydroxybutanoic acid composition being nominally 25-33 weight percent. The nucleating masterbatch was cyanuric acid that had been previously compounded at a rate of 33% (by weight) into a base resin of 3-hydroxybutanoic acid and 4-hydroxybutanoic acid, and pelleted. The slip anti-block masterbatch was a mixture of erucamide (20% by weight) diatomaceous earth (15% by weight) nucleant masterbatch (3% by weight), pelleted into PHA (62% by weight). The peroxide was tert-butylperoxy-2-ethylhexylcarbonate (available from Akzo Nobel as TRIGANOX® 117). PE3A was pentaerythritol triacrylate.

    [0167] The formulation was compounded into pellets, which were then used to make cast film using a 1.905 cm (3/4 inch) RandCastle extruder.

    [0168] Monolayer film was made from the above formulation. Monolayer PBSA film was also made. Coextruded film was also made, of composition PBSA/PHA Formulation/PBSA.

    [0169] The same PHA formulation was combined with various antimicrobial agents to produce monolayer extruded films, as described above. PolySept® Z (available from PolyChem Alloy) is a organic salt based, non-migratory antimicrobial. "UDA" is Urtica dioica agglutinin. AgION is a silver compound. AMICAL® 48 is diiodomethyl p-tolyl sulfone.

    [0170] Biodegradability of the films was tested by soil burial for three weeks. The results are shown in the table and the graph below.
    Table 10. Weight Loss of Extruded Films Buried in Soil
      Week 2Week 3
    Film No.thickness (mm)weight loss (g)thickness (mm)weight loss (g)
    1 PHA Blend monolayer film (10 mil) 0.276 0.007 0.284 0.063
    2 PBSA (2 mil) 0.064 0.004 0.060 0.008
    3 PBSA/PHA/PBSA (35 take up) 0.100 0.007 0.102 0.018
    4 PBSA/PHA/PBSA (70 take up) 0.096 0.007 0.106 0.014
    5 PHA Blend monolayer film + 0.5% PolySept® Z 0.190 0.004 0.193 0.011
    6 PHA Blend monolayer film + 1.0% PolySept® Z 0.245 0.002 0.240 0.002
    7 PHA Blend monolayer film + 1.0% UDA 0.239 0.008 0.233 0.034
    8 PHA Blend monolayer film + 2.5% UDA 0.233 0.009 0.235 0.032
    9 PHA Blend monolayer film + 0.5% AgION 0.245 0.014 0.234 0.044
    10 PHA Blend monolayer film + 2.0% AgION 0.229 0.004 0.252 0.028
    11 PHA Blend monolayer film + 0.1% AMICAL® 48 0.205 0.007 0.191 0.013
    12 PHA Blend monolayer film + 0.8% AMICAL® 48 0.216 0.008 0.229 0.009


    [0171] The PBSA monolayer film degraded more slowly than the monolayer film made from the PHA blend.

    [0172] As shown above, the PHA blend with added antimicrobial agents such as AMICAL® 48 and PolySept® Z degraded more slowly than the equivalent PHA blend film made without antimicrobial agents included. It degraded at approximately the same rate as PBSA film.

    Example 10. Blown Films Containing PBS or PBSA.



    [0173] In this example, blown films were made and tested for biodegradability. The following PHA formulation was made.
    Table 11. PHA Formulation for Blown Film
    IngredientWt %
    PHA Blend 78.00
    Nucleating Masterbatch 3.00
    Calcium Carbonate 5.00
    Slip Antiblock Masterbatch 5.00
    CITROFLEX® A4 8.73
    Peroxide 0.18
    PE3A 0.09


    [0174] The PHA blend was composed of about 34-38% homo-polymer of 3-hydroxybutanoic acid, and about 22-26% co-polymer of 3-hydroxybutanoic acid and 4-hydroxybutanoic acid, where the 4-hydroxybutanoic acid is approximately 8-14 weight percent, and about 38-42% co-polymer of 3-hydroxybutanoic acid and 4-hydroxybutanoic acid with the 4-hydroxybutanoic acid composition being nominally 25-33 weight percent. The nucleating masterbatch was cyanuric acid that had been previously compounded at a rate of 33% (by weight) into a base resin of 3-hydroxybutanoic acid and 4-hydroxybutanoic acid, and pelleted. The slip anti-block masterbatch was a mixture of erucamide (20% by weight) diatomaceous earth (15% by weight) nucleant masterbatch (3% by weight), pelleted into PHA (62% by weight). The peroxide was tert-butylperoxy-2-ethylhexylcarbonate (available from Akzo Nobel as TRIGANOX® 117). PE3A was pentaerythritol triacrylate.

    [0175] This PHA formulation was then combined with PBS or PBSA, in ratios of 90/10 (formulations 2 and 5), 75/25 (formulations 3 and 6), and 60/40 (formulations 4 and 7) ratios of PHA blend and PBS or PBSA, as shown.
    Table 12. Formulations for Blown Film
    Ingredient12345678
    PHA Formulation 78.00 70.2 58.5 46.8 70.2 58.5 46.8 58.5
    PBS - 7.8 19.5 31.2 - - - -
    PBSA - - - - 7.8 19.5 31.2 -


    [0176] Blown films were made from these formulations, and tested by soil burial. The results are shown in the table and the graph below.
    Table 13. Weight Loss of Blown Films Made with Antimicrobial Agents
      Week 2Week 3
    Film No. thickness (mm)weight loss (g)thickness (mm)weight loss (g)
    1 PHA Blend monolayer film 0.058 0.007 0.063 0.018
    2 PHA Blend / PBS monolayer film (90/10) 0.070 0.009 0.039 0.010
    3 PHA Blend / PBS monolayer film (75/25) 0.062 0.006 0.057 0.015
    4 PHA Blend / PBS monolayer film (60/40) 0.046 0.007 0.068 0.013
    5 PHA Blend / PBSA monolayer film (90/10) 0.045 0.011 0.071 0.018
    6 PHA Blend / PBSA monolayer film (75/25) 0.059 0.007 0.057 0.011
    7 PHA Blend / PBSA monolayer film (60/40) 0.065 0.008 0.049 0.012


    [0177] Films 2 - 7 showed a slower rate of weight loss relative to the control (film no. 1).

    Example 11. Compositions Containing PHBV and PBSA with Organic Peroxide



    [0178] In several previous examples, it was shown that when PHA/PBS and PHA/PBSA formulations are prepared by melt-blending in the presence of a reactive compound such as an organic peroxide, some synergistic rheological observations are evident. These formulations, created in a reactive environment, displayed considerably higher melt strength and better melt stability compared to formulations created without peroxide; the PHA phase also crystallized at a higher temperature in these formulations.

    [0179] The present example shows data for a PHBV (7% HV) melt-compounded with PBSA in the presence of an organic peroxide. The relative proportions of the PHBV and PBSA phases were varied while all other additives (plasticizer) were kept unchanged. Formulations 1-4 were made without peroxide while Formulations 5-8 included 0.2% by wt. peroxide. The compositions are described in Table 14 below along with the melt viscosity, melt strength and melt stability data. All formulations were compounded using a 27 mm MAXX Leistritz co-rotating twin-screw extruder with the ten barrels and die zones set at 175 / 175 / 170 / 170 / 170 / 165 / 165 / 165 / 160 / 160 (°C).
    Table 14. Compositions containing PHBV and PBSA reactively blended with peroxide.
    Component (Wt%)12345678
    PHBV* 95 85 75 65 95 85 75 65
    PBSA BIONOLLE® 3001 0 10 20 30 0 10 20 30
    CITROFLEX® A4 5 5 5 5 4.8 4.8 4.8 4.8
    Peroxide 0 0 0 0 0.2 0.2 0.2 0.2
    Total (Wt%) 100 100 100 100 100 100 100 100
    Torsional Melt Rheology
    G'@ 0.25 rad/s (Pa) 3 3 17 47 68 22 616 757
    Eta* @ 0.25 rad/s (Pa.s) 520 521 759 1088 904 798 4182 4418
    Capillary Melt Rheology
    Eta @ 5 min (Pa.s) 341 339 359 373 330 375 414 532
    Capillary Melt Stability -0.13 -0.11 -0.10 -0.10 -0.12 -0.12 -0.09 - 0.08
    *PHBV in the above table was previously compounded with nucleating agent and plasticizer


    [0180] The PBSA blended with PHBV was BIONOLLE® 3001 (Showa Highpolymer Co., Ltd., Japan). The peroxide used in this example was TRIGONOX® 131 (tert-amylperoxy 2-ethylhexyl carbonate) from Akzo Nobel. The data in Table 14 shows that with the addition of PBSA, the melt strength was improved by a factor of 16 compared to the PHBV composite. Marginal improvements with PBSA addition were also observed for the melt stability and viscosity. However with the addition of the peroxide, the melt strength improved by a factor of 250 for the highest level of PBSA added. The melt stability also improved by 39% while the melt viscosities were also shown to improve.

    Example 12. Compositions Containing PHA, PBS, Organic Peroxide and Co-agent



    [0181] In this example, rheological data for a PHA reactively melt-compounded with PBS in the presence of an organic peroxide and co-agent is presented. The proportions of the PHA and PBS phases as well as the additive were kept constant while the concentrations of peroxide and co-agent were varied. Other additives included in the formulations were SUPERCOAT™ calcium carbonate (Imerys Performance Minerals), a Plasticizer Masterbatch which was a 50/50 mixture of the plasticizers CITROFLEX® A4 (Vertellus Specialties Inc.) and PARAPLEX™ 8600 (Hallstar); a Slip/antiblock Master Batch which was a mixture composed of 15% by wt. Erucamide (Croda), 15% by wt. OPTIBLOC™ 10 talc filler (Specialty Minerals), a nucleating agent master batch Nuc. MB #1 which was composed of cyanuric acid compounded at 33% by wt. into a base PHA resin of 3-hydroxybutanoic acid and 4-hydroxybutanoic acid and 68% by wt. PHA copolymer blend composed of about 34-38% homo-polymer of 3-hydroxybutanoic acid, and about 22-26% co-polymer of 3-hydroxybutanoic acid and 4-hydroxybutanoic acid, where the 4-hydroxybutanoic acid is approximately 10-12 weight percent, and about 38-42% co-polymer of 3-hydroxybutanoic acid and 4-hydroxybutanoic acid with the 4-hydroxybutanoic acid composition being nominally 30 weight percent; peroxide branching agent (Akzo Nobel) #1 - TRIGONOX® 101 (2,5-di(tert-butylperoxy)hexane) and #2 - TRIGONOX® 131 (tert-amylperoxy 2-ethylhexyl carbonate); co-agent SR231 diethyleneglycol dimethacrylate (Sartomer). The PBS was BIONOLLE® 1001 (Showa Highpolymer Co., Ltd., Japan). The PHA was a blend composed of about 34-38% homo-polymer of 3-hydroxybutanoic acid, and about 22-26% co-polymer of 3-hydroxybutanoic acid and 4-hydroxybutanoic acid, where the 4-hydroxybutanoic acid is approximately 8-14 weight percent, and about 38-42% co-polymer of 3-hydroxybutanoic acid and 4-hydroxybutanoic acid with the 4-hydroxybutanoic acid composition being nominally 25-33 weight percent. The compositions are described in Table 15 below along with the melt viscosity and melt strength data.

    [0182] All formulations were compounded using a 26 mm Coperion co-rotating, twin-screw extruder using the following temperatures (from feed to die) 100/175 to 180/190/150/139/141/138/140/152/158 to 160/174/220 (°C), screw speed was 350rpm and die pressure 1.1928 x 107 Pa (1730 psi).
    Table 15. Compositions containing PHA and PBS reactively blended with peroxide and co-agent.
    Component (Wt%)1234
    PHA 45 45 45 45
    PBS BIONOLLE® 1001 30 30 30 30
    CaCO3 10 10 10 10
    Nuc. MB #1 3 3 3 3
    Slip/antiblock MB 4 4 4 4
    Plasticizer MB 7.87 7.92 7.93 7.95
    Peroxide #1 0 0 0.04 0.03
    Peroxide #2 0.08 0.05 0 0
    Co-agent SR231 0.05 0.03 0.03 0.02
    Total (Wt%) 100 100 100 100
    Torsional Melt    
    Rheology    
    G' @ 0.25 rad/s (Pa) 2383 1216 1651 1945
    Eta* @ 0.25 rad/s (Pa.s) 14620 9710 13380 14390
    The data in Table 15 shows that the type and amount of peroxide and co-agent used to reactively blend the PBS with PHA can have an effect on the rheological properties of the final mixture. Therefore the type and amount of peroxide/co-agent in the formulation needs to be optimized together in order to maximize the melt properties for each blend.

    [0183] When numerical ranges are set forth herein, these ranges are inclusive of the recited range end points (i.e., end points may be used). When percentages by weight are used herein, the numerical values reported are relative to the total weight.

    [0184] Also, it should be understood that any numerical range recited herein is intended to include all sub-ranges subsumed therein. For example, a range of "1 to 10" is intended to include all sub-ranges between (and including) the recited minimum value of 1 and the recited maximum value of 10, that is, having a minimum value equal to or greater than 1 and a maximum value of equal to or less than 10. The terms "one," "a," or "an" as used herein are intended to include "at least one" or "one or more," unless otherwise indicated.

    [0185] Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs.


    Claims

    1. A method of preparing a branched polymer composition, comprising
    reacting a polyhydroxyalkanoate (PHA) and poly(butylene succinate-co-adipate) (PBSA) with a branching agent, thereby forming a branched polymer composition of PHA and PBSA.
     
    2. The method of Claim 1, wherein the branching agent is selected from: dicumyl peroxide, t-amyl-2-ethylhexyl peroxycarbonate, 1,1-bis(t-butylperoxy)-3,3,5-trimethylcyclohexane, 2,5-dimethyl-2,5-di(t-butylperoxy) hexane, 2,5-bis(t-butylperoxy)-2,5-dimethylhexane, 2,5-dimethyl-di(t-butylperoxy)hexyne-3, di-t-butyl peroxide, benzoyl peroxide, di-t-amyl peroxide, t-butyl cumyl peroxide, n-butyl-4,4-bis(t-butylperoxy)valerate, 1,1-di(t-butylperoxy)-3,3,5-trimethyl-cyclohexane, 1,1-di(t-butylperoxy)cyclohexane, 1,1-di(t-amylperoxy)-cyclohexane, 2,2-di(t-butylperoxy)butane, ethyl-3,3-di(t-butylperoxy)butyrate, 2,2-di(t-amylperoxy)propane, ethyl-3,3-di(t-amylperoxy)butyrate, t-butylperoxy-acetate, t-amylperoxyacetate, t-butylperoxybenzoate, t-amylperoxybenzoate, and di-t-butyldiperoxyphthalate, optionally wherein the concentration of branching agent is between 0.001% to 0.5% by weight of the total composition.
     
    3. The method of Claim 1 or Claim 2, wherein the composition further comprises a cross-linking agent for reacting with the polymer composition.
     
    4. The method of Claim 3, wherein the cross-linking agent:

    (a) contains at least two reactive C-C double bonds;

    (b) is an epoxy functional compound;

    (c) is diallyl phthalate, pentaerythritol tetraacrylate, trimethylolpropane triacrylate, pentaerythritol triacrylate, dipentaerythritol pentaacrylate, diethylene glycol dimethacrylate, bis (2-methacryloxyethyl) phosphate, or combinations thereof; or

    (d) is an epoxy-functional styrene-acrylic polymer, an epoxy-functional acrylic copolymer, an epoxy-functional polyolefin copolymer, an oligomer comprising a glycidyl group with an epoxy functional side chain, an epoxy-functional poly(ethylene-glycidyl methacrylate-co-methacrylate), or an epoxidized oil or combinations thereof.


     
    5. The method of any one of the preceding claims, further comprising a nucleating agent.
     
    6. The method of any one of the preceding claims, wherein the amount of PHA in the polymer composition is 5% to 95%, 20%-60% or 30%-50% by weight of the composition.
     
    7. The method of Claim 1 or Claim 2, wherein:

    the branched polymer composition is prepared by melt-blending a PHA and PBSA and a branching agent, thereby forming a molten branched polymer composition; and

    wherein the method further comprises the step of forming an article from the molten branched polymer composition;
    thereby making an article comprising the polymer composition of branched PHA and branched PBSA.


     
    8. The method of Claim 7, wherein the article is an injection molded article, wherein the injection molded article:

    (a) is annealed;

    (b) has increased tensile strength as measured ASTM D638-03, relative to a corresponding injection molded article consisting of PHA;

    (c) has increased impact strength as measured by ASTM D256-06, relative to a corresponding injection molded article consisting of PHA; or

    (d) biodegrades more slowly than a corresponding PHA injection molded article consisting of PHA.


     
    9. The method of Claim 1, wherein the composition further comprises one or more additives, and wherein the additive is an anti-microbial agent.
     
    10. The method of any one of the preceding claims, wherein the PHA is:

    a poly(3-hydroxybutyrate) homopolymer;

    a poly(3-hydroxybutyrate-co-4-hydroxybutyrate), optionally with 5% to 15% 4-hydroxybutyrate content;

    a poly(3-hydroxybutyrate-co-3-hydroxyvalerate), optionally with 5% to 22% 3-hydroxyvalerate content;

    a poly(3-hydroxybutyrate-co-5-hydroxyvalerate), optionally with 5% to 15% 5-hydroxyvalerate content;

    a poly(3-hydroxybutyrate-co-3-hydroxyhexanoate), optionally with 3% to 15% 3-hydroxyhexanoate content;

    a) a poly(3-hydroxybutyrate) homopolymer blended with

    b) a poly(3-hydroxybutyrate-co-4-hydroxybutyrate), optionally with a 5% to 15% 4-hydroxybutyrate content,

    b) a poly(3-hydroxybutyrate-co-3-hydroxyvalerate), optionally with a 5% to 22% 3-hydroxyvalerate content or

    b) a poly(3-hydroxybutyrate-co-3-hydroxyhexanoate), optionally with a 3% to 15% 3-hydroxyhexanoate content;

    a) a poly(3-hydroxybutyrate-co-4-hydroxybutyrate) blended with

    b) a poly(3-hydroxybutyrate-co-3-hydroxyvalerate) or

    b) a poly(3-hydroxybutyrate-co-3-hydroxyhexanoate);

    a) a poly(3-hydroxybutyrate-co-3-hydroxyvalerate) blended with
    b) a poly(3-hydroxybutyrate-co-3-hydroxyhexanoate);

    a) a poly(3-hydroxybutyrate-co-4-hydroxybutyrate) with a 5% to 15% 4-hydroxybutyrate content blended with

    b) a poly(3-hydroxybutyrate-co-3-hydroxyvalerate) with a 5% to 22% 3-hydroxyvalerate content or

    b) a poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) with a 3% to 15% 3-hydroxyhexanoate content; or

    a) a poly(3-hydroxybutyrate-co-3-hydroxyvalerate) with a 5% to 22% 3-hydroxyvalerate content blended with
    b) a poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) with a 3% to 15% 3-hydroxyhexanoate content.


     
    11. The method of Claim 10, wherein the PHA is:

    (i) a) a poly(3-hydroxybutyrate) homopolymer blended with

    b) a poly(3-hydroxybutyrate-co-4-hydroxybutyrate),

    b) a poly(3-hydroxybutyrate-co-3-hydroxyvalerate) or

    b) a poly(3-hydroxybutyrate-co-3-hydroxyhexanoate)
    and the weight of polymer a) is 5% to 95% of the combined weight of polymer a) and polymer b);

    (ii) a) a poly(3-hydroxybutyrate-co-4-hydroxybutyrate) blended with

    b) a poly(3-hydroxybutyrate-co-3-hydroxyvalerate) or

    b) a poly(3-hydroxybutyrate-co-3-hydroxyhexanoate)
    and the weight of polymer a) is 5% to 95% of the combined weight of polymer a) and polymer b); or

    (iii) a) a poly(3-hydroxybutyrate-co-3-hydroxyvalerate) blended with
    b) a poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) and the weight of polymer a) is 5% to 95% of the combined weight of polymer a) and polymer b), optionally wherein the weight of polymer a) is 20 % to 60% of the combined weight of polymer a) and polymer b) and the weight of polymer b) is 40% to 80% of the combined weight of polymer a) and polymer b).


     
    12. The method of any one of Claims 1 to 9, wherein the PHA is:

    (i) a) poly(3-hydroxybutyrate) homopolymer blended with

    b) a poly(3-hydroxybutyrate-co-4-hydroxybutyrate) with a 20-50% 4-hydroxybutyrate content,

    b) a poly(3-hydroxybutyrate-co-5-hydroxyvalerate) with a 20% to 50% 5-hydroxyvalerate content or

    b) a poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) having a 5%-50% 3-hydroxyhexanoate content;

    (ii) a) poly(3-hydroxybutyrate-co-4-hydroxybutyrate) with a 5% to 15% 4-hydroxybutyrate content blended with

    b) a poly(3-hydroxybutyrate-co-4-hydroxybutyrate) with a 20-50% 4-hydroxybutyrate content,

    b) a poly(3-hydroxybutyrate-co-5-hydroxyvalerate) with a 20% to 50% 5-hydroxyvalerate content or

    b) a poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) having a 5%-50% 3-hydroxyhexanoate content;

    (iii) a) a poly(3-hydroxybutyrate-co-3-hydroxyvalerate) with a 5% to 22% 3-hydroxyvalerate content blended with

    b) poly(3-hydroxybutyrate-co-4-hydroxybutyrate) with a 20-50% 4-hydroxybutyrate content,

    b) a poly(3-hydroxybutyrate-co-5-hydroxyvalerate) with a 20% to 50% 5-hydroxyvalerate content or

    b) a poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) having a 5%-50% 3-hydroxyhexanoate content;

    (iv) a) a poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) with a 3% to 15% 3-hydroxyhexanoate content blended with

    b) a poly(3-hydroxybutyrate-co-4-hydroxybutyrate) with a 20-50% 4-hydroxybutyrate content,

    b) a poly(3-hydroxybutyrate-co-5-hydroxyvalerate) with a 20% to 50% 5-hydroxyvalerate content or

    b) a poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) having a 5%-50% 3-hydroxyhexanoate content.

    optionally wherein
    the weight of polymer a) is 5% to 95% of the combined weight of polymer a) and polymer b) or
    the weight of polymer a) is 20 % to 60% of the combined weight of polymer a) and polymer b) and the weight of polymer b is 40% to 80% of the combined weight of polymer a) and polymer b).


     
    13. The method of any one of Claims 10 to 12, wherein the PHA is further blended with:

    c) a poly(3-hydroxybutyrate-co-4-hydroxybutyrate) with a 20% to 50% 4-hydroxybutyrate content;

    c) a poly(3-hydroxybutyrate-co-5-hydroxyvalerate) with a 20% to 50% 5-hydroxyvalerate content; or

    c) a poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) with a 5% to 50% 3-hydroxyhexanoate content,
    optionally wherein the weight of polymer c) is 5% to 95% of the combined polymer weight of polymer a), polymer b) and polymer c).


     
    14. The method of Claim 13, wherein the weight of polymer c) is 5% to 40% of the combined polymer weight of polymer a), polymer b) and polymer c).
     
    15. A composition obtainable by the method of any one of the preceding claims.
     
    16. An article obtainable by the method of any one of Claims 7 to 14.
     
    17. The article of Claim 16, wherein the article is film
    and wherein, optionally, the film is blown or extruded and/or the film is annealed, and wherein the annealed film optionally has 25% greater tear resistance according to ASTM D1922-06, 25% greater puncture resistance according to D1709-04, or 25% greater tensile strength according to D882-02 than a corresponding PHA film made without PBSA.
     
    18. A composition comprising a branched polyhydroxyalkanoate (PHA) and branched poly(butylene succinate-co-adipate) (PBSA).
     
    19. The composition of Claim 18, wherein the PHA is:

    (i) a PHA blend of 58-62% homo-polymer of 3-hydroxybutanoic acid, and 38-42% copolymer of 3-hydroxybutanoic acid and 4-hydroxybutanoic acid, wherein the content of the 4-hydroxybutanoic acid in the copolymer is 8-14% weight percent; or

    (ii) a blend of

    34-38% of a homo-polymer of 3-hydroxybutanoic acid,

    22-26% of a co-polymer of 3-hydroxybutanoic acid and 4-hydroxybutanoic acid, wherein the content of 4-hydroxybutanoic acid is 8-14 weight percent, and

    38-42% of a co-polymer of 3-hydroxybutanoic acid and 4-hydroxybutanoic acid, wherein the content of 4-hydroxybutanoic acid is 25-33 weight percent.


     
    20. An article comprising the composition of Claim 18 or Claim 19.
     


    Ansprüche

    1. Verfahren zur Herstellung einer verzweigten Polymerzusammensetzung, umfassend
    Umsetzen eines Polyhydroxyalkanoats (PHA) und eines Poly(butylensuccinat-co-adipats) (PBSA) mit einem Verzweigungsmittel, um eine verzweigte Polymerzusammensetzung von PHA und PBSA zu bilden.
     
    2. Verfahren gemäß Anspruch 1, wobei das Verzweigungsmittel ausgewählt ist aus:

    Dicumylperoxid, t-Amyl-2-ethylhexylperoxycarbonat, 1,1-Bis(t-butylperoxy)-3,3,5-trimethylcyclohexan, 2,5-Dimethyl-2,5-di(t-butylperoxy)hexan, 2,5-Bis(t-butylperoxy)-2,5-dimethylhexan, 2,5-Dimethyl-di(t-butylperoxy)hexin-3, Di-t-butylperoxid, Benzoylperoxid, Di-t-amylperoxid, t-Butylcumylperoxid, n-Butyl-4,4-bis(t-butylperoxy)valerat, 1,1 -Di(t-butylperoxy)-3,3,5-trimethylcyclohexan, 1,1-Di(t-butylperoxy)cyclohexan, 1,1-Di(t-amylperoxy)cyclohexan, 2,2-Di(t-butylperoxy)butan, Ethyl-3,3-di(t-butylperoxy)butyrat, 2,2-Di(t-amylperoxy)propan, Ethyl-3,3-di(t-amylperoxy)butyrat, t-Butylperoxyacetat, t-Amylperoxyacetat, t-Butylperoxybenzoat,

    t-Amylperoxybenzoat und Di-t-butyldiperoxyphthalat, wobei die Konzentration an Verzweigungsmittel gegebenenfalls zwischen 0,001 Gew.-% und 0,5 Gew.-% der gesamten Zusammensetzung beträgt.


     
    3. Verfahren gemäß Anspruch 1 oder Anspruch 2, wobei die Zusammensetzung ferner einen Vernetzer zur Reaktion mit der Polymerzusammensetzung umfasst.
     
    4. Verfahren gemäß Anspruch 3, wobei der Vernetzer:

    (a) wenigstens zwei reaktionsfähige C-C-Doppelbindungen enthält;

    (b) eine epoxyfunktionelle Verbindung ist;

    (c) Diallylphthalat, Pentaerythritoltetraacrylat, Trimethylolpropantriacrylat, Pentaerythritoltriacrylat, Dipentaerythritolpentaacrylat, Diethylenglycoldimethacrylat, Bis(2-methacryloxyethyl)phosphat oder Kombinationen davon ist; oder

    (d) ein epoxyfunktionelles Styrol-Acryl-Polymer, ein epoxyfunktionelles AcrylCopolymer, ein epoxyfunktionelles Polyolefin-Copolymer, ein Oligomer, das eine Glycidylgruppe mit einer epoxyfunktionellen Seitenkette umfasst, ein epoxyfunktionelles Poly(ethylenglycidylmethacrylat-co-methacrylat) oder ein epoxidiertes Öl oder Kombinationen davon ist.


     
    5. Verfahren gemäß einem der vorstehenden Ansprüche, ferner umfassend einen Keimbildner.
     
    6. Verfahren gemäß einem der vorstehenden Ansprüche, wobei die Menge an PHA in der Polymerzusammensetzung 5 Gew.-% bis 95 Gew.-%, 20 Gew.-% bis 60 Gew.-% oder 30 Gew.-% bis 50 Gew.-% der Zusammensetzung beträgt.
     
    7. Verfahren gemäß Anspruch 1 oder Anspruch 2, wobei

    die verzweigte Polymerzusammensetzung durch Schmelzmischen eines PHA und PBSA und eines Verzweigungsmittels hergestellt wird, um eine geschmolzene verzweigte Polymerzusammensetzung zu bilden; und

    wobei das Verfahren ferner den Schritt des Formens eines Gegenstands aus der geschmolzenen verzweigten Polymerzusammensetzung umfasst;
    um einen Gegenstand herzustellen, der die Polymerzusammensetzung von verzweigtem PHA und verzweigtem PBSA umfasst.


     
    8. Verfahren gemäß Anspruch 7, wobei der Gegenstand ein spritzgegossener Gegenstand ist, wobei der spritzgegossene Gegenstand:

    (a) getempert ist;

    (b) eine erhöhte Zugfestigkeit, wie gemessen gemäß ASTM D638-03, im Vergleich zu einem entsprechenden spritzgegossenen Gegenstand, der aus PHA besteht, aufweist;

    (c) eine erhöhte Schlagfestigkeit, wie gemessen gemäß ASTM D256-06, im Vergleich zu einem entsprechenden spritzgegossenen Gegenstand, der aus PHA besteht, aufweist; oder

    (d) langsamer als ein entsprechender PHA- spritzgegossener Gegenstand, der aus PHA besteht, biologisch abgebaut wird.


     
    9. Verfahren gemäß Anspruch 1, wobei die Zusammensetzung ferner einen oder mehrere Zusatzstoffe umfasst und wobei der Zusatzstoff ein antimikrobielles Mittel ist.
     
    10. Verfahren gemäß einem der vorstehenden Ansprüche, wobei das PHA ist:

    ein Poly(3-hydroxybutyrat)-Homopolymer;

    ein Poly(3-hydroxybutyrat-co-4-hydroxybutyrat), gegebenenfalls mit 5 % bis 15 % 4-Hydroxybutyrat-Gehalt;

    ein Poly(3-hydroxybutyrat-co-3-hydroxyvalerat), gegebenenfalls mit 5 % bis 22 % 3-Hydroxyvalerat-Gehalt;

    ein Poly(3-hydroxybutyrat-co-5-hydroxyvalerat), gegebenenfalls mit 5 % bis 15 % 5-Hydroxyvalerat-Gehalt;

    ein Poly(3-hydroxybutyrat-co-3-hydroxyhexanoat), gegebenenfalls mit 3 % bis 15 % 3-Hydroxyhexanoat-Gehalt;

    a) ein Poly(3-hydroxybutyrat)-Homopolymer, gemischt mit

    b) einem Poly(3-hydroxybutyrat-co-4-hydroxybutyrat), gegebenenfalls mit einem 5 % bis 15 % 4-Hydroxybutyrat-Gehalt,

    b) einem Poly(3-hydroxybutyrat-co-3-hydroxyvalerat), gegebenenfalls mit einem 5 % bis 22 % 3-Hydroxyvalerat-Gehalt, oder

    b) einem Poly(3-hydroxybutyrat-co-3-hydroxyhexanoat), gegebenenfalls mit einem 3 % bis 15 % 3-Hydroxyhexanoat-Gehalt;

    a) ein Poly(3-hydroxybutyrat-co-4-hydroxybutyrat), gemischt mit

    b) einem Poly(3-hydroxybutyrat-co-3-hydroxyvalerat) oder

    b) einem Poly(3-hydroxybutyrat-co-3-hydroxyhexanoat);

    a) ein Poly(3-hydroxybutyrat-co-3-hydroxyvalerat), gemischt mit
    b) einem Poly(3-hydroxybutyrat-co-3-hydroxyhexanoat);

    a) ein Poly(3-hydroxybutyrat-co-4-hydroxybutyrat) mit einem 5 % bis 15 % 4-Hydroxybutyrat-Gehalt, gemischt mit

    b) einem Poly(3-hydroxybutyrat-co-3-hydroxyvalerat) mit einem 5 % bis 22 % 3-Hydroxyvalerat-Gehalt oder

    b) einem Poly(3-hydroxybutyrat-co-3-hydroxyhexanoat) mit einem 3 % bis 15 % 3-Hydroxyhexanoat-Gehalt; oder

    a) ein Poly(3-hydroxybutyrat-co-3-hydroxyvalerat) mit einem 5 % bis 22 % 3-Hydroxyvalerat-Gehalt, gemischt mit
    b) einem Poly(3-hydroxybutyrat-co-3-hydroxyhexanoat) mit einem 3 % bis 15 % 3-Hydroxyhexanoat-Gehalt.


     
    11. Verfahren gemäß Anspruch 10, wobei das PHA ist:

    (i) a) ein Poly(3-hydroxybutyrat)-Homopolymer, gemischt mit

    b) einem Poly(3-hydroxybutyrat-co-4-hydroxybutyrat),

    b) einem Poly(3-hydroxybutyrat-co-3-hydroxyvalerat) oder

    b) einem Poly(3-hydroxybutyrat-co-3-hydroxyhexanoat),
    und wobei das Gewicht von Polymer a) 5 % bis 95 % des kombinierten Gewichts von Polymer a) und Polymer b) beträgt;

    (ii) a) ein Poly(3-hydroxybutyrat-co-4-hydroxybutyrat), gemischt mit

    b) einem Poly(3-hydroxybutyrat-co-3-hydroxyvalerat) oder

    b) einem Poly(3-hydroxybutyrat-co-3-hydroxyhexanoat),
    und wobei das Gewicht von Polymer a) 5 % bis 95 % des kombinierten Gewichts von Polymer a) und Polymer b) beträgt; oder

    (iii) a) ein Poly(3-hydroxybutyrat-co-3-hydroxyvalerat), gemischt mit
    b) einem Poly(3-hydroxybutyrat-co-3-hydroxyhexanoat), und wobei das Gewicht von Polymer a) 5 % bis 95 % des kombinierten Gewichts von Polymer a) und Polymer b) beträgt,
    gegebenenfalls wobei das Gewicht von Polymer a) 20 % bis 60 % des kombinierten Gewichts von Polymer a) und Polymer b) beträgt und das Gewicht von Polymer b) 40 % bis 80 % des kombinierten Gewichts von Polymer a) und Polymer b) beträgt.


     
    12. Verfahren gemäß einem der Ansprüche 1 bis 9, wobei das PHA ist:

    (i) a) ein Poly(3-hydroxybutyrat)-Homopolymer, gemischt mit

    b) einem Poly(3-hydroxybutyrat-co-4-hydroxybutyrat) mit einem 20-50 % 4-Hydroxybutyrat-Gehalt,

    b) einem Poly(3-hydroxybutyrat-co-5-hydroxyvalerat) mit einem 20 % bis 50 % 5-Hydroxyvalerat-Gehalt oder

    b) einem Poly(3-hydroxybutyrat-co-3-hydroxyhexanoat) mit einem 5 % bis 50 % 3-Hydroxyhexanoat-Gehalt;

    (ii) a) Poly(3-hydroxybutyrat-co-4-hydroxybutyrat) mit einem 5 % bis 15 % 4-Hydroxybutyrat-Gehalt, gemischt mit

    b) einem Poly(3-hydroxybutyrat-co-4-hydroxybutyrat) mit einem 20-50 % 4-Hydroxybutyrat-Gehalt,

    b) einem Poly(3-hydroxybutyrat-co-5-hydroxyvalerat) mit einem 20 % bis 50 % 5-Hydroxyvalerat-Gehalt oder

    b) einem Poly(3-hydroxybutyrat-co-3-hydroxyhexanoat) mit einem 5 % bis 50 % 3-Hydroxyhexanoat-Gehalt;

    (iii) a) ein Poly(3-hydroxybutyrat-co-3-hydroxyvalerat) mit einem 5 % bis 22 % 3-Hydroxyvalerat-Gehalt, gemischt mit

    b) Poly(3-hydroxybutyrat-co-4-hydroxybutyrat) mit einem 20-50 % 4-Hydroxybutyrat-Gehalt,

    b) einem Poly(3-hydroxybutyrat-co-5-hydroxyvalerat) mit einem 20 % bis 50 % 5-Hydroxyvalerat-Gehalt oder

    b) einem Poly(3-hydroxybutyrat-co-3-hydroxyhexanoat) mit einem 5 % bis 50 % 3-Hydroxyhexanoat-Gehalt;

    (iv) a) ein Poly(3-hydroxybutyrat-co-3-hydroxyhexanoat) mit einem 3 % bis 15 % 3-Hydroxyhexanoat-Gehalt, gemischt mit

    b) einem Poly(3-hydroxybutyrat-co-4-hydroxybutyrat) mit einem 20-50 % 4-Hydroxybutyrat-Gehalt,

    b) einem Poly(3-hydroxybutyrat-co-5-hydroxyvalerat) mit einem 20 % bis 50 % 5-Hydroxyvalerat-Gehalt oder

    b) einem Poly(3-hydroxybutyrat-co-3-hydroxyhexanoat) mit einem 5 % bis 50 % 3-Hydroxyhexanoat-Gehalt,
    gegebenenfalls wobei
    das Gewicht von Polymer a) 5 % bis 95 % des kombinierten Gewichts von Polymer a) und Polymer b) beträgt oder
    das Gewicht von Polymer a) 20 % bis 60 % des kombinierten Gewichts von Polymer a) und Polymer b) beträgt und das Gewicht von Polymer b) 40 % bis 80 % des kombinierten Gewichts von Polymer a) und Polymer b) beträgt.


     
    13. Verfahren gemäß einem der Ansprüche 10 bis 12, wobei das PHA ferner gemischt wird mit:

    c) einem Poly(3-hydroxybutyrat-co-4-hydroxybutyrat) mit einem 20 % bis 50 % 4-Hydroxybutyrat-Gehalt;

    c) einem Poly(3-hydroxybutyrat-co-5-hydroxyvalerat) mit einem 20 % bis 50 % 5-Hydroxyvalerat-Gehalt; oder

    c) einem Poly(3-hydroxybutyrat-co-3-hydroxyhexanoat) mit einem 5 % bis 50 % 3-Hydroxyhexanoat-Gehalt,
    wobei gegebenenfalls das Gewicht von Polymer c) 5 % bis 95 % des kombinierten Polymergewichts von Polymer a), Polymer b) und Polymer c) beträgt.


     
    14. Verfahren gemäß Anspruch 13, wobei das Gewicht von Polymer c) 5 % bis 40 % des kombinierten Polymergewichts von Polymer a), Polymer b) und Polymer c) beträgt.
     
    15. Zusammensetzung, erhältlich durch das Verfahren gemäß einem der vorstehenden Ansprüche.
     
    16. Gegenstand, erhältlich durch das Verfahren gemäß einem der Ansprüche 7 bis 14.
     
    17. Gegenstand gemäß Anspruch 16, wobei der Gegenstand ein Film ist,
    und wobei gegebenenfalls der Film geblasen oder extrudiert ist und/oder der Film getempert ist,
    und wobei der getemperte Film eine 25 % höhere Reißfestigkeit gemäß ASTM D1922-06, 25 % höhere Durchstoßfestigkeit gemäß D1709-04 oder 25 % höhere Zugfestigkeit gemäß D882-02 als ein entsprechender PHA-Film, der ohne PBSA hergestellt ist, aufweist.
     
    18. Zusammensetzung, umfassend ein verzweigtes Polyhydroxyalkanoat (PHA) und verzweigtes Poly(butylensuccinat-co-adipat) (PBSA).
     
    19. Zusammensetzung gemäß Anspruch 18, wobei das PHA ist:

    (i) ein PHA-Gemisch von 58-62 % Homopolymer von 3-Hydroxybutansäure und 38-42 % Copolymer von 3-Hydroxybutansäure und 4-Hydroxybutansäure, wobei der Gehalt an der 4-Hydroxybutansäure in dem Copolymer 8-14 Gew.-% beträgt; oder

    (ii) ein Gemisch von

    34-38 % an einem Homopolymer von 3-Hydroxybutansäure,

    22-26 % an einem Copolymer von 3-Hydroxybutansäure und 4-Hydroxybutansäure, wobei der Gehalt an 4-Hydroxybutansäure 8-14 Gewichtsprozent beträgt, und

    38-42 % an einem Copolymer von 3-Hydroxybutansäure und 4-Hydroxybutansäure, wobei der Gehalt an 4-Hydroxybutansäure 25-33 Gewichtsprozent beträgt.


     
    20. Gegenstand, umfassend die Zusammensetzung gemäß Anspruch 18 oder Anspruch 19.
     


    Revendications

    1. Procédé de préparation d'une composition de polymère ramifié, comprenant
    la mise en réaction d'un polyhydroxyalcanoate (PHA) et d'un poly(succinate de butylène-co-adipate) (PBSA) avec un agent de ramification, formant ainsi une composition de polymère ramifié de PHA et de PBSA.
     
    2. Procédé selon la revendication 1, l'agent de ramification étant choisi parmi :

    peroxyde de dicumyle, peroxycarbonate de t-amyl-2-éthylhexyle, 1,1-bis(t-butylperoxy)-3,3,5-triméthylcyclohexane, 2,5-diméthyl-2,5-di(t-butylperoxy)hexane, 2,5-bis(t-butylperoxy)-2,5-diméthylhexane, 2,5-diméthyl-di(t-butylperoxy)hexyne-3,

    peroxyde de di-t-butyle, peroxyde de benzoyle, peroxyde de di-t-amyle, t-peroxyde de butyle et de cumyle, 4,4-bis(t-butylperoxy)valérate de n-butyle, 1,1-di(t-butylperoxy)-3,3,5-triméthyl-cyclohexane, 1,1 -di(t-butylperoxy)cyclohexane, 1,1 -di(t-amylperoxy)-cyclohexane, 2,2-di(t-butylperoxy)butane, 3,3-di(t-butylperoxy)butyrate d'éthyle, 2,2-di(t-amylperoxy)propane, 3,3-di(t-amylperoxy)butyrate d'éthyle, t-butylperoxyacétate, t-amylperoxyacétate, t-butylperoxybenzoate, t-amylperoxybenzoate, et di-t-butyldiperoxyphtalate, éventuellement la concentration d'agent de ramification étant comprise entre 0,001 % et 0,5 % en poids de la composition totale.


     
    3. Procédé selon la revendication 1 ou la revendication 2, la composition comprenant en outre un agent de réticulation pour la mise en réaction avec la composition de polymère.
     
    4. Procédé selon la revendication 3, l'agent de réticulation :

    (a) contenant au moins deux doubles liaisons C-C réactives ;

    (b) étant un composé fonctionnalisé par époxy ;

    (c) étant le phtalate de diallyle, le tétraacrylate de pentaérythritol, le triacrylate de triméthylolpropane, le triacrylate de pentaérythritol, le pentaacrylate de dipentaérythritol, le diméthacrylate de diéthylèneglycol, le bis (2-méthacryloxyéthyl)phosphate, ou des combinaisons correspondantes ; ou

    (d) étant un polymère styrène-acrylique fonctionnalisé par époxy, un copolymère acrylique fonctionnalisé par époxy, un copolymère de polyoléfine fonctionnalisé par époxy, un oligomère comprenant un groupe glycidyle doté d'une chaîne latérale fonctionnalisée par époxy, un poly (éthylène-méthacrylate de glycidyle-co-méthacrylate) fonctionnalisé par époxy, ou une huile époxydée ou des combinaisons correspondantes.


     
    5. Procédé selon l'une quelconque des revendications précédentes, comprenant en outre un agent de nucléation.
     
    6. Procédé selon l'une quelconque des revendications précédentes, la quantité de PHA dans la composition de polymère étant de 5 % à 95 %, 20 % à 60 % ou 30 % à 50 % en poids de la composition.
     
    7. Procédé selon la revendication 1 ou la revendication 2,

    la composition de polymère ramifié étant préparée par mélange à l'état fondu d'un PHA et d'un PBSA et d'un agent de ramification, formant ainsi une composition de polymère ramifié fondue ; et

    le procédé comprenant en outre l'étape de formation d'un article à partir de la composition de polymère ramifié fondue ;
    fabricant ainsi un article comprenant la composition de polymère de PHA ramifié et de PBSA ramifié.


     
    8. Procédé selon la revendication 7, l'article étant un article moulé par injection, l'article moulé par injection :

    (a) étant recuit ;

    (b) possédant une résistance à la traction accrue telle que mesurée selon la norme ASTM D638-03, par rapport à un article moulé par injection correspondant constitué de PHA ;

    (c) possédant une résistance aux chocs accrue telle que mesurée selon la norme ASTM D256-06, par rapport à un article moulé par injection correspondant constitué de PHA ; ou

    (d) étant biodégradé plus lentement qu'un article moulé par injection de PHA correspondant constitué de PHA.


     
    9. Procédé selon la revendication 1, la composition comprenant en outre un ou plusieurs additifs, et l'additif étant un agent antimicrobien.
     
    10. Procédé selon l'une quelconque des revendications précédentes, le PHA étant :

    un homopolymère de poly(3-hydroxybutyrate) ;

    un poly(3-hydroxybutyrate-co-4-hydroxybutyrate), éventuellement doté d'une teneur en 4-hydroxybutyrate de 5 % à 15 % ;

    un poly(3-hydroxybutyrate-co-3-hydroxyvalérate), éventuellement doté d'une teneur en 3-hydroxyvalérate de 5 % à 22 % ;

    un poly(3-hydroxybutyrate-co-5-hydroxyvalérate), éventuellement doté d'une teneur en 5-hydroxyvalérate de 5 % à 15 % ;

    un poly(3-hydroxybutyrate-co-3-hydroxyhexanoate), éventuellement doté d'une teneur en 3-hydroxyhexanoate de 3 % à 15 % ;

    a) un homopolymère de poly(3-hydroxybutyrate) mélangé avec

    b) un poly(3-hydroxybutyrate-co-4-hydroxybutyrate), éventuellement doté d'une teneur en 4-hydroxybutyrate de 5 % à 15 % ;

    b) un poly(3-hydroxybutyrate-co-3-hydroxyvalérate), éventuellement doté d'une teneur en 3-hydroxyvalérate de 5 % à 22 % ; ou

    b) un poly(3-hydroxybutyrate-co-3-hydroxyhexanoate), éventuellement doté d'une teneur en 3-hydroxyhexanoate de 3 % à 15 % ;

    a) un poly(3-hydroxybutyrate-co-4-hydroxybutyrate) mélangé avec

    b) un poly(3-hydroxybutyrate-co-3-hydroxyvalérate) ou

    b) un poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) ;

    a) un poly(3-hydroxybutyrate-co-3-hydroxyvalérate) mélangé avec
    b) un poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) ;

    a) un poly(3-hydroxybutyrate-co-4-hydroxybutyrate) doté d'une teneur en 4-hydroxybutyrate de 5 % à 15 % mélangé avec

    b) un poly(3-hydroxybutyrate-co-3-hydroxyvalérate) doté d'une teneur en 3-hydroxyvalérate de 5 % à 22 % ou

    b) un poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) doté d'une teneur en 3-hydroxyhexanoate de 3 % à 15 % ; ou

    a) un poly(3-hydroxybutyrate-co-3-hydroxyvalérate) doté d'une teneur en 3-hydroxyvalérate de 5 % à 22 % mélangé avec
    b) un poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) doté d'une teneur en 3-hydroxyhexanoate de 3 % à 15 %.


     
    11. Procédé selon la revendication 10, le PHA étant :

    (i) a) un homopolymère de poly(3-hydroxybutyrate) mélangé avec

    b) un poly(3-hydroxybutyrate-co-4-hydroxybutyrate),

    b) un poly(3-hydroxybutyrate-co-3-hydroxyvalérate) ou

    b) un poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) et le poids du polymère a) étant de 5 % à 95 % du poids combiné du polymère a) et du polymère b) ;

    (ii) a) un poly(3-hydroxybutyrate-co-4-hydroxybutyrate) mélangé avec

    b) un poly(3-hydroxybutyrate-co-3-hydroxyvalérate) ou

    b) un poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) et le poids du polymère a) étant de 5 % à 95 % du poids combiné du polymère a) et du polymère b) ; ou

    (iii) a) un poly(3-hydroxybutyrate-co-3-hydroxyvalérate) mélangé avec
    b) un poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) et le poids du polymère a) étant de 5 % à 95 % du poids combiné du polymère a) et du polymère b),
    éventuellement le poids du polymère a) étant de 20 % à 60 % du poids combiné du polymère a) et du polymère b) et le poids du polymère b) étant de 40 % à 80 % du poids combiné du polymère a) et du polymère b).


     
    12. Procédé selon l'une quelconque des revendications 1 à 9, le PHA étant :

    (i) a) un homopolymère de poly(3-hydroxybutyrate) mélangé avec

    b) un poly(3-hydroxybutyrate-co-4-hydroxybutyrate) doté d'une teneur en 4-hydroxybutyrate de 20 % à 50 %,

    b) un poly(3-hydroxybutyrate-co-5-hydroxyvalérate) doté d'une teneur en 5-hydroxyvalérate de 20 % à 50 % ou

    b) un poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) doté d'une teneur en 3-hydroxyhexanoate de 5 % à 50 % ;

    (ii) a) un poly(3-hydroxybutyrate-co-4-hydroxybutyrate) doté d'une teneur en 4-hydroxybutyrate de 5 % à 15 % mélangé avec

    b) un poly(3-hydroxybutyrate-co-4-hydroxybutyrate) doté d'une teneur en 4-hydroxybutyrate de 20 % à 50 %,

    b) un poly(3-hydroxybutyrate-co-5-hydroxyvalérate) doté d'une teneur en 5-hydroxyvalérate de 20 % à 50 % ou

    b) un poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) doté d'une teneur en 3-hydroxyhexanoate de 5 % à 50 % ;

    (iii) a) un poly(3-hydroxybutyrate-co-3-hydroxyvalérate) doté d'une teneur 3-hydroxyvalérate de 5 % à 22 % mélangé avec

    b) un poly(3-hydroxybutyrate-co-4-hydroxybutyrate) doté d'une teneur en 4-hydroxybutyrate de 20 % à 50 %,

    b) un poly(3-hydroxybutyrate-co-5-hydroxyvalérate) doté d'une teneur en 5-hydroxyvalérate de 20 % à 50 % ou

    b) un poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) doté d'une teneur en 3-hydroxyhexanoate de 5 % à 50 % ;

    (iv) a) un poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) doté d'une teneur en 3-hydroxyhexanoate de 3 % à 15 % mélangé avec

    b) un poly(3-hydroxybutyrate-co-4-hydroxybutyrate) doté d'une teneur en 4-hydroxybutyrate de 20 % à 50 %,

    b) un poly(3-hydroxybutyrate-co-5-hydroxyvalérate) doté d'une teneur en 5-hydroxyvalérate de 20 % à 50 % ou

    b) un poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) doté d'une teneur en 3-hydroxyhexanoate de 5 % à 50 % ;
    éventuellement
    le poids du polymère a) étant de 5 % à 95 % du poids combiné du polymère a) et du polymère b) ou
    le poids du polymère a) étant de 20 % à 60 % du poids combiné du polymère a) et du polymère b) et le poids du polymère b) étant de 40 % à 80 % du poids combiné du polymère a) et du polymère b).


     
    13. Procédé selon l'une quelconque des revendications 10 à 12, le PHA étant en outre mélangé avec :

    c) un poly(3-hydroxybutyrate-co-4-hydroxybutyrate) doté d'une teneur en 4-hydroxybutyrate de 20 % à 50 % ;

    c) un poly(3-hydroxybutyrate-co-5-hydroxyvalérate) doté d'une teneur en 5-hydroxyvalérate de 20 % à 50 % ; ou

    c) un poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) doté d'une teneur en 3-hydroxyhexanoate de 5 % à 50 %,
    éventuellement le poids du polymère c) étant de 5 % à 95 % du poids de polymère combiné du polymère a), du polymère b) et du polymère c).


     
    14. Procédé selon la revendication 13, le poids du polymère c) étant de 5 % à 40 % du poids de polymère combiné du polymère a), du polymère b) et du polymère c).
     
    15. Composition pouvant être obtenue par le procédé selon l'une quelconque des revendications précédentes.
     
    16. Article pouvant être obtenu par le procédé selon l'une quelconque des revendications 7 à 14.
     
    17. Article selon la revendication 16, l'article étant un film
    et, éventuellement, le film étant soufflé ou extrudé et/ou le film étant recuit, et le film recuit possédant éventuellement une résistance à la déchirure 25 % plus grande,
    selon la norme ASTM D1922-06, une résistance à la perforation 25 % plus grande, selon la norme D1709-04, ou une résistance à la traction 25 % plus grande, selon la norme D882-02, qu'un film de PHA correspondant fabriqué sans PBSA.
     
    18. Composition comprenant un polyhydroxyalcanoate (PHA) ramifié et un poly(succinate de butylène-co-adipate) (PBSA) ramifié.
     
    19. Composition selon la revendication 18, le PHA étant :

    (i) un mélange de PHA de 58 à 62 % d'homopolymère d'acide 3-hydroxybutanoïque, et 38 à 42 % de copolymère d'acide 3-hydroxybutanoïque et d'acide 4-hydroxybutanoïque, la teneur de l'acide 4-hydroxybutanoïque dans le copolymère étant de 8 à 14 pour cent en poids ; ou

    (ii) un mélange de

    34 à 38 % d'un homopolymère d'acide 3-hydroxybutanoïque,

    22 à 26 % d'un copolymère d'acide 3-hydroxybutanoïque et d'acide 4-hydroxybutanoïque, la teneur en acide 4-hydroxybutanoïque étant de 8 à 14 pour cent en poids, et

    38 à 42 % d'un copolymère d'acide 3-hydroxybutanoïque et d'acide 4-hydroxybutanoïque, la teneur en acide 4-hydroxybutanoïque étant de 25 à 33 pour cent en poids.


     
    20. Article comprenant la composition selon la revendication 18 ou selon la revendication 19.
     




    Drawing























    Cited references

    REFERENCES CITED IN THE DESCRIPTION



    This list of references cited by the applicant is for the reader's convenience only. It does not form part of the European patent document. Even though great care has been taken in compiling the references, errors or omissions cannot be excluded and the EPO disclaims all liability in this regard.

    Patent documents cited in the description




    Non-patent literature cited in the description